US20030191506A1 - Method and apparatus for electromedical theraphy - Google Patents

Method and apparatus for electromedical theraphy Download PDF

Info

Publication number
US20030191506A1
US20030191506A1 US10/257,582 US25758203A US2003191506A1 US 20030191506 A1 US20030191506 A1 US 20030191506A1 US 25758203 A US25758203 A US 25758203A US 2003191506 A1 US2003191506 A1 US 2003191506A1
Authority
US
United States
Prior art keywords
electrodes
therapeutic electrical
electrical signal
therapeutic
platform
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US10/257,582
Inventor
Boris Shloznikov
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roamitron Holding SA
Original Assignee
Roamitron Holding SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roamitron Holding SA filed Critical Roamitron Holding SA
Priority to US10/257,582 priority Critical patent/US20030191506A1/en
Assigned to ROAMITRON HOLDING S.A. reassignment ROAMITRON HOLDING S.A. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SHLOZNIKOV, BORIS
Publication of US20030191506A1 publication Critical patent/US20030191506A1/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014External stimulators, e.g. with patch electrodes
    • A61N1/36021External stimulators, e.g. with patch electrodes for treatment of pain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/0404Electrodes for external use
    • A61N1/0408Use-related aspects
    • A61N1/0456Specially adapted for transcutaneous electrical nerve stimulation [TENS]

Definitions

  • This invention relates to a method and apparatus for use in electromedical therapy. More particularly, the present invention relates to a method and apparatus for applying a therapeutic electrical signal to regions of a user's body.
  • the therapeutic signal could be used for any type of therapy, including to relieve pain, to relieve stress, to apply electronic acupuncture and for transcutaneous electrical nerve stimulation (TENS).
  • TENS transcutaneous electrical nerve stimulation
  • U.S. Pat. No. 3,851,651 to Icenbice, Jr. discloses an electrical facial stimulator having eight individual electrodes in total attached to different parts of the face. The electrodes are energized to electrically stimulate the user's facial nerves and muscles.
  • the facial stimulator of Icenbice accordingly, provides a small number of electrodes which can be energized at a small and specific part of the user's body, namely specific parts of the face.
  • U.S. Pat. No. 5,527,357 to Springer discloses a mask having a rigid outer lining providing the required structural integrity to hold about ten electrodes at specific locations over the face.
  • the electrodes provide electrical signals to ten specific critical points on the face. Accordingly, Springer also suffers from the disadvantage that the mask provides a relatively small number of electrodes which provide electrical signals to a small and specific part of the user's face.
  • the prior art devices suffer from several disadvantages.
  • One of these disadvantages include that the prior art devices generally only apply the electrical signal to a small region of the body at one time.
  • Another disadvantage is that the prior art devices often require an assistant to apply the therapy.
  • Another disadvantage is that the therapeutic effects of the prior art devices are limited by the corresponding habituative effects caused by the patient's own body.
  • a further disadvantage is that the electrical signals applied by the prior art devices often cause pain, burns and/or other discomfort to the patient because of the nature and the shape of the electrical signal being applied.
  • a still further disadvantage of the prior art devices is that their beneficial effects are limited to the duration of the procedure, and do not provide any lingering beneficial effects which continue after the procedure is completed.
  • this invention resides in an apparatus for providing therapeutic electrical signals, said apparatus comprising: a signal generator for generating the therapeutic electrical signal; a plurality of sets of electrodes, each set of electrodes comprising at least two electrodes for applying the therapeutic electrical signal to a user; and a switching unit for selectively switching the therapeutic electrical signal to each set of electrodes in a predetermined pattern.
  • the present invention resides in a method for providing therapeutic electrical signals, said method comprising the steps of: (a)generating a therapeutic electrical signal; (b) providing a plurality of sets of electrodes, each set of electrodes comprising at least two electrodes for applying the therapeutic electrical signal to a user; and (c) selectively switching the therapeutic electrical signal to each set of electrodes of the plurality of sets of electrodes in a predetermined pattern.
  • one advantage of the present invention is that a plurality of sets of electrodes are used to apply the therapeutic electrical signal.
  • a large surface of the user can be treated at any one time without the need to move the apparatus over the user's body. This makes it easier to apply the therapeutic electrical signal to the user. Furthermore, this makes it easier for the user to use the apparatus on themselves without an assistant.
  • the electrodes are arranged on a platform which permits electrodes to substantially conform to the surface of the user. This facilitates application of the therapeutic electrical signal to surfaces of regions of the user's body which are not generally flat. For example, this permits the platform to conform to variations in the user's back, such as around the spine. This also facilitates application of the therapeutic electrical signal to the lower back of the patient, such as along the acupuncture meridian, which may result in release of enkefalins by the body to relieve stress.
  • the present invention provides a flexible platform upon which the electrodes are contained.
  • the entire platform, including the electrodes can substantially conform to the surface of the user for improving the contact of the electrodes to the surface or skin of the user.
  • the flexible platform is separate and remote from the control unit to decrease the mass of the flexible platform and make it easier to apply and/or strap to the body.
  • a further advantage of the present invention is that it comprises a plurality of sets of electrodes to which the therapeutic electrical signal is applied in a predetermined pattern. Accordingly, while a large number of electrodes are available to be used in order to cover a large surface area of the user, the therapeutic electrical signal is only applied to a set of electrodes at any one time. In this way, the therapeutic electrical signal may be applied to electrodes proximate each other, permitting the therapeutic electrical signal to have a smaller electrical potential than would be required if the electrodes were distant from each other. Furthermore, this permits the switch to apply the therapeutic electrical signals in a predetermined pattern to achieve the best coverage and therapeutic benefit to the user. For example, in a preferred embodiment, the switch will apply the therapeutic electrical signal to a next set of electrodes in the plurality of electrodes every 0.5 to 2 seconds in order to avoid habituative effects.
  • a still further advantage of the present invention is that the therapeutic electrical signals can be applied to the sets of electrodes in a predetermined pattern.
  • the user can control how the therapeutic electrical signals are applied, including the area, duration and type of therapeutic signal.
  • the predetermined pattern will be selected so as to decrease the habituation effect.
  • the predetermined pattern can also be selected to provide lingering beneficial effects that continue after the procedure is completed. This can result, for example, by selecting a predetermined pattern that promotes generation of endorphins that are retained in the body.
  • the therapeutic electrical signal is applied to the acupuncture meridian, the body may generate enkefalins which will relieve stress.
  • the user can be ensured that the therapeutic electrical signal will not be applied to the same set of electrodes consecutively. Applying the therapeutic electrical signal to the same set of electrodes consecutively could result in overexposure of the therapeutic electrical signals to a particular region of the user's body that may cause discomfort to the patient and/or promote habituation effects.
  • the therapeutic electrical signal can have characteristics which may decrease or eliminate pain while maintaining an effective therapeutic level. This is accomplished, in part, by the therapeutic electrical signal comprising a base wave having a relatively high frequency of about 150 KHz to 180 KHz and more preferably 160 to 170 KHz and the base wave is preferably applied about 2 to 100 times per second.
  • the base wave of the therapeutic electrical signal preferably decreases from its maximum to its minimum in about 0.2 to 0.01 microseconds.
  • the integral of the base wave over a cycle is zero.
  • the predetermined pattern may comprise different types of therapeutic electrical signals.
  • the switching unit will selectively switch between different types of therapeutic electrical signals to each set of electrodes in a predetermined pattern.
  • the patient will be exposed to different types of therapeutic electrical signals that may have different beneficial effects.
  • the habituation effects may also decrease.
  • changing the types of therapeutic electrical signals, as well as limiting the duration that the switch may apply the therapeutic electrical signal to each set of electrodes to about 0.5 to 2 seconds reduces the effects of the brain filters thereby reducing habituation effects, and may cause lingering beneficial effects which continue after the therapy is completed.
  • a further advantage of the present invention is that an electroconductive substance can be applied to the electrodes to increase electroconductivity. Because the electrodes tend to be stationary, the electroconductive substance will remain between the skin or surface of the user and the electrodes. Further, such electroconductive substance generally have the consistency of a gel which gives them an adhesive quality. In this way, the electroconductive substance can assist in keeping the electrodes in contact with the skin. Furthermore, in the case when the platform does not have a great deal of mass, such as when a flexible platform is used, the adhesive qualities of the electroconductive substance may be sufficient to maintain the flexible platform in place, especially flexible platform embodiment.
  • FIGS. 1A and 1B are bottom and side views, respectively, of a device according to one embodiment of the present invention.
  • FIG. 2 is a schematic diagram showing the components of the apparatus for applying the therapeutic electrical signal
  • FIG. 3 is a bottom elevation view of the device according to one embodiment of the present invention.
  • FIG. 4 is a timing diagram showing the base wave according to one embodiment of the present invention.
  • FIGS. 5A, 5B and 5 C are timing diagrams showing different types of therapeutic electrical signals that may be applied in a predetermined pattern according to one embodiment of the present invention
  • FIG. 6 is a perspective view of a device according to a further embodiment of the present invention having a housing separated from the platform;
  • FIG. 7A is a top view of an upper part of the flexible platform
  • FIG. 7B is a bottom view of the lower part of the flexible platform.
  • FIG. 8 is a diagram of an assembled flexible platform showing the wiring for the electrodes.
  • FIG. 1A is a bottom elevation view and FIG. 1B is a side elevation view of an apparatus, shown generally by reference numeral 10 , for providing therapeutic electrical signals according to one embodiment of the present invention.
  • the apparatus 10 comprises a housing 12 which, in this embodiment, houses the plurality of electrodes 60 .
  • the housing 12 also houses other components, including input/output devices, such as a keypad and LEDs 16 , as well as a power source, such as battery pack 8 .
  • the housing 12 preferably has an opening 112 for straps 114 . In this way, the apparatus 10 can be strapped or fastened to a part of the user, such as the lower back or a leg, with straps 114 .
  • the plurality of electrodes 60 are mounted on a platform 50 that permits relative movement of the electrodes 60 .
  • the platform 50 and/or the plurality of electrodes 60 on the platform 50 will be able to substantially conform to a surface of the user so that each of the plurality of electrodes 60 is in contact with a surface of the user, even if the surface of the user is not a flat surface.
  • the platform 50 may be flexible to permit the electrodes to substantially conform to the surface of the body. In one preferred embodiment, shown in FIGS.
  • the platform 50 is made from a flexible, non-conductive material, such as rubber or mylar, which permits the plurality of electrodes 60 to substantially conform to a surface of the user and also electrically insulates the plurality of electrodes 60 from each other.
  • the plurality of electrodes 60 could move relative to the platform 50 , but be biased outwards so as to substantially conform to the surface of the patient. In either case, it is apparent that the platform 50 would permit the plurality of electrodes 60 to substantially conform to a surface of the user.
  • the plurality of electrodes 60 preferably comprise nipples 61 .
  • the plurality of electrodes 60 may comprise at least one, and preferably more, nipples 61 to assist in decreasing the electrical contact resistance between the plurality of electrodes 60 and the surface of the user.
  • each electrode 60 has nine nipples 61 .
  • FIG. 2 is a schematic diagram symbolically showing the components of the apparatus 10 for applying the therapeutic electrical signal according to one embodiment.
  • the apparatus 10 comprises input/output devices, such as a keypad and LEDs 16 , as well as a power source, such as a battery pack 8 , which are also illustrated in FIGS. 1A and 1B.
  • the apparatus 10 can also comprise a wall mount adapter 18 and a power supply and trickle charger 20 , which together form a power unit to both supply power to the apparatus 10 and charge the battery pack 8 for later use.
  • the power supply and trickle charger 20 is connected to the keypad and LED 16 to supply power to this component.
  • the keypad and LED 16 together with the power supply and trickle charger 20 , are connected to the signal timing generator 22 to both supply power to the signal timing generator 22 and also send and receive input/output signals from the keypad and LED 16 .
  • the keypad and LED 16 can send and receive input/output signals to the signal timing generator 22 which specify predetermined patterns and types of therapeutic electrical signals which should be applied to the plurality of electrodes 60 and which predetermined patterns are being applied.
  • the signal timing generator 22 comprises a microcontroller, such as a microprocessor.
  • the signal timing generator 22 is connected to a plurality of switches 26 .
  • the signal timing generator 22 actuates the plurality of switches 26 to selectively switch the therapeutic electrical signal to the plurality of electrodes 60 .
  • the plurality of electrodes 60 are grouped into a plurality of sets of electrodes 60 a to 60 t.
  • the switches 26 selectively switch the therapeutic electrical signal to each of the sets of electrodes 60 a to 60 t in a predetermined pattern.
  • the first group of switches 26 a switch the therapeutic electrical signal to the first set 60 a of the plurality of sets of electrodes 60 a to 60 t.
  • the first set of electrodes 60 a comprises the outer electrode pair no. 1 and the common electrode no. 1 .
  • the first set of electrodes 60 a comprises three electrodes, namely a common electrode in the centre and a pair of outer electrodes.
  • the apparatus 10 comprises a 20th set of electrodes 60 t comprising outer electrode pair no. 20 and common electrode no. 20 . Therefore, the 20th set of electrodes 60 t also comprises three electrodes with a common electrode in the centre and a pair of outer electrodes.
  • the signal timing generator 22 switches the therapeutic electrical signal to the 20th set of electrodes 60 t by actuating the 20th group of switches 26 t. While not shown in FIG. 2, it is apparent that the plurality of switches 26 would comprise switches 26 b to 26 s to switch the therapeutic electrical signal to each set of electrodes 60 b to 60 s.
  • FIG. 2 there are 20 sets of electrodes comprising three electrodes for a total of 60 electrodes. However, it is understood that different sets of electrodes and different numbers of electrodes in each set can be used.
  • the signal timing generator 22 and the plurality of switches 26 form the switching unit, shown generally by reference numeral 25 .
  • the switching unit 25 is used to send the therapeutic electrical signals selectively to each of the plurality of sets of electrodes 60 a to 60 t in a predetermined pattern.
  • the therapeutic electrical signal is generated by the signal generator 24 .
  • the signal, generator 24 will generate a base signal or base wave b w that is then selectively switched by the switching unit 25 to each one of the plurality of sets of electrodes 60 a to 60 t.
  • the signal generator 24 is connected to the signal timing generator 22 to control the base wave b w so as to produce the predetermined pattern and control the type of therapeutic electrical signal being generated.
  • the signal generator 24 is also connected to a power source, which in this embodiment is the battery pack 8 , to draw sufficient power to generate the therapeutic electrical signal and the base wave b w that forms the therapeutic electrical signal.
  • the base wave b w will have a wave form shown in FIG. 4 by reference numeral b w .
  • the base wave b w will have a frequency of between 150 KHz to 180 KHz, and more preferably 160 KHz to 170 KHz. In the preferred embodiment shown in FIG. 4, the base wave b w has a frequency of about 166 KHz.
  • the period of the base wave b w will be about 6 microseconds.
  • the base wave b w will decrease quickly from its maximum to its minimum.
  • the base wave b w will decrease from its maximum value b max of about positive 50V to its minimum value b min of about negative 17V in a time t which preferably is within about 0.2 to 0.01 microseconds and still more preferably within about 0.1 to 0.01 microseconds.
  • the time t is most preferable about 0.05 microseconds.
  • the therapeutic electrical signal comprises the base wave b w .
  • the therapeutic electrical signal is not identical to the base wave b w . Rather, it is preferred that the therapeutic electrical signal comprises bursts of the base wave b w .
  • the therapeutic electrical signal preferably comprises bursts of the base wave b w at specific frequencies, such as 2 to 100 times in a second, and the base wave b w would be quiet or not applied at other times.
  • FIG. 5A shows a first therapeutic electrical signal tes a where the base wave b w is applied four times in a second. Therefore, the first therapeutic electrical signal tes a has a period of about 250 milliseconds and a frequency of 4 Hz. During the period of 250 milliseconds, the base wave b w is applied for about half that time, or 125 milliseconds. For the remaining period, namely 125 milliseconds, the base wave b w is not applied.
  • FIG. 5B shows a second therapeutic electrical signal tes b where the base wave b w is applied two times in a second.
  • the second therapeutic electrical signal tes b is applied in a burst of about 250 milliseconds and then is quiet or not applied for about 250 milliseconds. Accordingly, the second therapeutic electrical signal tes b has a period of about 500 milliseconds and a frequency of about 2 Hz.
  • FIG. 5C shows a third therapeutic electrical signal tes c that has a period of about 13 milliseconds, and therefore a frequency of about 77 Hz.
  • the base wave b w is applied for a burst of about 3 milliseconds followed by a quiet period where the base wave b w is not applied for about 10 milliseconds.
  • the third electrical signal tes c applies the base wave b w 77 times in a second, but for only about 3 milliseconds each time.
  • the apparatus 10 can apply any of the therapeutic electrical signal tes a , tes b , tes c , or any other type of therapeutic electrical signal.
  • the therapeutic electrical signal will comprise a base wave b w applied at a frequency of about 2 to 100 times per second.
  • the duration or burst during which the base wave b w is applied can vary and may not correspond to half of the period, as illustrated by the third therapeutic electrical signal tes c in FIG. 5C.
  • the predetermined pattern of the apparatus 10 may comprise different types of therapeutic electrical signals, as described more fully below.
  • FIG. 3 shows the bottom elevation of the apparatus 10 , similar to the view shown in FIG. 1A.
  • each of the plurality of sets of electrodes 60 a to 60 t comprise at least three electrodes 60 arranged in a substantially chevron pattern.
  • the first set of electrodes 60 a shown in FIG. 3 comprise electrodes 1 , 2 and 3 .
  • the last set of electrodes 60 t comprise electrodes 4 , 5 and 6 . It is apparent that the twenty chevron patterns between the first set of electrodes 60 a and the last set of electrodes 60 t illustrate each set of the plurality of sets of electrodes 60 a to 60 t of the embodiment illustrated in FIG. 3.
  • the centre electrode such as electrodes 2 and 5 , of the plurality of sets of electrodes 60 a to 60 t, have a potential that is opposite to the potential of the side electrodes 1 , 3 and 4 , 6 .
  • centre electrodes 2 , 5 may have different electrical switches 26 from the side electrodes. This is illustrated in FIG. 2 where the first group of switches 26 a comprise switches 26 ao and 26 ac. Switch 26 ao actuates the outer electrode pair no. 1 corresponding to electrodes 1 and 3 and switch 26 ac actuates the common electrode no. 1 corresponding to electrode 2 .
  • the 20th group of switches 26 comprise switches 26 tc and 26 to. Switch 26 th actuates the outer electrode pair no. 20 corresponding to electrodes 4 and 6 and switch 26 tc actuates the common electrode no. 20 corresponding to electrode 5 .
  • the chevron pattern of electrodes illustrated in FIG. 3 is a preferred embodiment and is selected to permit a relatively large area to be effected by the therapeutic electrical signal, while at the same time having the electrodes fairly near each other so that the voltage may not be too large to overcome the natural resistance of the body. Nevertheless, it is understood that other arrangements of electrodes, other than a chevron pattern, including a square pattern, a circular or semi-circular pattern or even a straight line, could be used provided each set of electrodes 60 a to 60 t have at least two electrodes through which the therapeutic electrical signal may pass.
  • electrodes a, b, c, d, e, f do not form a chevron pattern with other electrodes, and therefore would not be used in the embodiment shown in FIG. 3.
  • electrodes a, b, c, d, e, f may have electrical signal passing through them.
  • the switching unit 25 will apply the therapeutic electrical signal to the plurality of sets of electrodes 60 a to 60 t in the predetermined pattern.
  • the predetermined pattern may be any pattern that switches the therapeutic electrical signal to each set of electrodes 60 a to 60 t in a controlled manner without causing the therapeutic electrical signal to be switched to the same set of electrodes twice, thereby causing habituation effects.
  • the switching unit 25 will send the therapeutic electrical signal sequentially to each set of electrodes 60 a to 60 t.
  • the switching unit 25 will send the therapeutic electrical signal sequentially in a consecutive order commencing with the first set of electrodes 60 a at a first end 30 of the apparatus 10 and platform 50 and ending at the last set of electrodes 60 t at the second end 32 of the apparatus 10 and platform 50 .
  • the switching unit 25 may have a predetermined pattern which continuously and repeatedly sends the therapeutic electrical signal sequentially in this consecutive order from the first set of electrodes 60 a to the last set of electrodes 60 t.
  • the switching unit 25 may have a predetermined pattern which sends the therapeutic electrical signal in alternate directions “sweeping” across the platform 50 .
  • the switching unit 25 may first apply the therapeutic electrical signals in a first direction, shown generally by the arrows marked with reference numeral 41 , from the first end 30 to the second end 32 .
  • the switching unit 25 may then apply the therapeutic electrical signal in a second direction, shown generally by the arrows marked with reference numeral 42 , from the second end 32 to the first end 30 .
  • a sweep is considered to be an application of therapeutic electrical signals once across each of the sets of electrodes 60 a to 60 t in either direction 41 , 42 “sweeping” across the platform 50 .
  • the sets of electrodes 60 a to 60 t in the first direction 41 will be the same as the sets of electrodes 60 t to 60 a in the second direction 42 .
  • the therapeutic electrical signal will be applied to the same three electrodes in each set of electrodes 60 a to 60 t in both directions 41 , 42 .
  • the present invention is not limited to this embodiment. Rather, the sets of electrodes 60 a to 60 t in the first direction 41 may differ from the sets of electrodes 60 a to 60 t in the second direction 42 , provided there are at least two electrodes 60 in each set of electrodes 60 a to 60 t.
  • the therapeutic electrical signal need not be the same in each direction. Rather, in a preferred embodiment, the therapeutic electrical signal will change with each “sweep”. For example, as set out in Table A below, in sweep 1, which preferably is in a first direction 41 , the therapeutic electrical signal will correspond to the first therapeutic electrical signal tes a shown in FIG. 5A and will be sequentially and consecutively applied to each of the plurality of sets of electrodes 60 a to 60 t. In sweep 2, which is preferably in the second direction 42 , the therapeutic electrical signal will correspond to the second therapeutic electrical signal tes b illustrated in FIG. 5B.
  • the therapeutic electrical signal will correspond to the third therapeutic electrical signal tes c illustrated in FIG. 5C.
  • One advantage of the above is that the application of the base wave b, at the different frequencies, namely 4 Hz, 2 Hz and 77 Hz, will have different beneficial effects to the patient.
  • a frequency of about 77 Hz has been found to generate endorphins, and enkefalins which tend to relieve stress, and therefore it is preferred for a pain killing effect.
  • Generation of enkefalins have been found to be most pronounced when the apparatus 10 is applied to the acupuncture meridians along the lower back region.
  • the frequencies of 2 Hz and 4 Hz have been found to generate endorphins.
  • the apparatus 10 can apply the therapeutic electrical signals to the sets of electrodes 60 a to 60 t in a predetermined pattern.
  • the predetermined pattern of the apparatus 10 can comprise different types of therapeutic electrical signals tes a , tea b , tes c at different stages.
  • the therapeutic electrical signal is applied to a set of electrodes 60 a to 60 t for about 0.5 to 2 seconds.
  • the therapeutic electrical signals are applied to each set of electrodes 60 a to 60 t for a duration of about 1 second.
  • each sweep from one end 30 or 32 to the other end 32 or 30 will take about 20 seconds.
  • the predetermined pattern shown in Table A which comprises three sweeps and three types of therapeutic electrical signals tes a , tes b , tes c will therefore take about one minute.
  • the switch to a next set of electrodes 60 a to 60 t will occur during a quiet period when the base wave b w is not being applied.
  • the duration of 0.5 to 2 seconds is preferable because it is sufficient to generate endorphins and enkefalins.
  • a duration of 0.5 to 2 seconds is generally insufficient to permit the body to generate hormones that counteract the beneficial effects of endorphins and enkefalins.
  • habituation effects may decrease and the user may experience a build-up of endorphins and enkefalins. In this way, the user may experience a lingering effect from use of the apparatus 10 , at least in part because of the build-up of endorphins and enkefalins caused by the use of the apparatus 10 .
  • habituation effects may be further decreased because use of different types of therapeutic electrical signals tes a , tes b , tes c may bypass the brain filters which cause the habituation effects.
  • Habituation effects have been found to be further decreased by applying the different types of therapeutic electrical signals tes a , tes b , tes c to the user for a duration of not more than 0.5 to 2 seconds per set of electrodes 60 a to 60 t.
  • generating and applying different types of therapeutic electrical signals, tes a , tes b , tes c across a plurality of electrodes 60 not only helps to decrease habituation effects, but also provides more than one type of benefit to the user, and, the benefit the user may experience is more likely to linger after use of the apparatus 10 has ceased.
  • FIG. 6 shows an apparatus, shown generally by reference numeral 300 , accordingly a further embodiment of the present invention.
  • the apparatus 300 has a platform which is separate from a housing 310 which houses other components of the apparatus 300 , such as the signal generator 24 and switching unit 25 .
  • the housing 310 may also include input/output such as the keypad and LED 306 .
  • the housing 310 will also preferably contain a power supply and trickle charger 20 to supply a battery pack 8 and/or receive power from a wall mount adapter 18 , similar to the apparatus 10 described above.
  • the housing 310 is connected to the platform 50 by an electrical connection, shown generally by reference numeral 313 .
  • the electrical connection 313 in this embodiment comprises a first fixed electrical cable 312 from the housing 310 to a connector, such as an oyster connector 316 .
  • the first cable 312 is generally fixed to both the housing 310 at one end 311 and fixed to the connector 316 at the second end 318 .
  • the connector 316 is electrically connected to the components of the apparatus 300 , including the signal generator 24 .
  • the connector 316 shown in FIG. 6 is commonly referred to as an “oyster” connector, but it is understood that any type of connector can be used.
  • the connector 316 also comprises an input/output slot 319 which can releasably receive a first end 419 (shown in FIGS. 7A, 7B and 8 ) of a second removable cable 314 .
  • the second end 420 (shown in FIGS. 7A, 7B and 8 ) of the second cable 314 is connected, generally permanently to the platform 50 providing an electrical connection from the first end 419 of the second cable 314 to the electrodes 60 on the platform 50 .
  • the first end 419 of the second cable 314 may be releasably mated or received into the input/output slot 319 of the connector 316 to thereby releasably electively connect the components contained within the housing 310 , and in particular, the signal generator 24 , to the electrodes 60 on the platform 50 .
  • the connector 316 is integrally formed as part of the housing 310 such that the first fixed cable 312 is not needed, but rather the first end 419 of the second cable 314 would be releasably received in an input/output slot 319 in the housing 310 .
  • the advantages of the apparatus 300 shown in FIG. 6 include that the platform 50 can be removed from the connector 316 for maintenance and/or servicing. Furthermore, in a preferred embodiment, different types of platforms 50 , either having different size or different arrangements of electrodes 60 thereon, may be interchangeably releasably received into the slot 319 of the connector 316 . This gives the apparatus 300 shown in FIG. 6 increased versatility.
  • the platform 50 may be a flexible platform 350 , shown in FIG. 6, but illustrated and discussed below in more detail with respect to FIGS. 7A, 7B and 8 .
  • flexible platforms 350 are generally disposable such that after a number of uses, the first end 419 of the second cable 314 may be releasably removed from the slot 319 of the connector 316 and replaced with the first end 419 of another second cable 314 connected to another flexible platform (not shown).
  • flexible platforms 350 which are generally less resilient, may be replaced periodically and either disposed of or recycled.
  • FIG. 7A shows the top view of the upper part of the flexible platform 350 U.
  • the upper part of the flexible platform 350 U includes silver inking connectors 370 extending along the second cable 314 to the first end 419 .
  • the silver inking connectors 370 are electrically conductive and can conduct the therapeutic electrical signals received from the signal generator 24 through the switches 26 , the first cable 312 , the connector 316 and the second cable 314 .
  • the second cable 314 is integrally formed with the flexible platform 350 such that the silver inking connectors 370 will extend past the second end 420 to connections 340 .
  • the second cable 314 may be separate from the flexible platform 350 so that a further connector (not shown) would be present to connect the second end 420 of the second cable 314 to the flexible platform 350 .
  • the connections 340 are electrically connected to the centre electrodes 60 c shown as the middle row of the three rows of electrodes 60 in FIG. 7B.
  • the centre electrodes 60 c are actuated by the centre switches 26 ac to 26 tc as discussed above with respect to FIGS. 2, 3, 4 and 5 . In this way, the therapeutic electrical signals can be transmitted from the signal generator 24 to the centre electrodes 60 c.
  • FIG. 7B which shows the lower part of the flexible platform 350 L, likewise has silver inking connectors 371 extending along the second cable 314 to the first end 419 to receive the electrical therapeutic signal from the signal generator 24 , similar to the silver inking connectors 370 .
  • the silver inking connectors 371 in the lower part of the flexible platform 350 L extend to the outer electrodes 60 o shown at the two external rows in FIG. 7B.
  • the outer electrodes 60 o are actuated by the outer switches 26 ao to 26 to discussed above with respect to FIGS. 2, 3, 4 and 5 .
  • the silver inking connectors 370 on the upper part of the flexible platform 350 U will be electrically insulated from the silver inking connectors 371 on the lower part of the flexible platform 350 L. It is also apparent that while electrodes 60 are all present on the lower part of the flexible platform 350 L, the middle row will be electrically insulated from the outer two rows, except for electrical contact through the surface of the user through which therapeutic electrical signals will flow.
  • the upper and lower parts of the flexible platform 350 U and 350 L, respectively are manufactured from an insulated material upon which the silver inking connectors 370 , 371 may be applied.
  • the upper and lower parts of the flexible platforms 350 U and 350 L, respectively are manufactured from portions of mylar, but other substances, such as rubber, plastics, or other electrically insulated materials, could also be used.
  • the electrodes 60 will have an orientation such as a chevron, shown generally by reference numeral 365 .
  • the therapeutic electrical signal 60 will be applied along a chevron pattern, similar to that as discussed above with respect to the apparatus 10 .
  • the electrodes 60 on the flexible platform 350 can be used in the same manner as the electrodes 60 on the apparatus 10 discussed above.
  • FIG. 8 shows the flexible platform 350 in the assembled position with the upper part 350 U connected to the lower part 350 L such as by gluing, laminating or otherwise connecting the upper part 350 U to the lower part 350 L.
  • the silver inking connectors 370 , 371 overlap, but are electrically insulated. For instance, if the silver inking connectors 370 are on the upper surface 361 of the upper part of the flexible platform 350 L and the silver inking connectors 371 are on the lower surface 362 of the lower part of the flexible platform 350 L, then the upper and lower parts 350 U, 350 L, respectively, of the flexible platform 350 will act as the electrical insulation.
  • the silver inking connectors 370 are on the upper surface 361 of the flexible platform 350 and the silver inking connectors 371 are on the lower surface 362 of the flexible platform 350 when the parts 350 U, 350 L are assembled. It will be appreciated by persons skilled in the art that the same effect could be obtained by having a flexible platform 350 manufactured from a single layer of mylar, or other electrically insulative substance with the silver inking connectors 370 on the upper surface 361 and the silver inking connectors 371 on the lower surface 362 , rather than having two parts 350 U, 350 L connected together.
  • the flexible platform 350 may also comprise a strap 410 .
  • the strap 410 can be integrally formed with the flexible platform 350 .
  • the strap 410 can be used to strap the flexible platform 350 to a region of the user, such as an arm or leg.
  • the strap 410 may also be wrapped around the connector 316 to assist in holding the first end 419 of the second cable 314 to the cable 316 .
  • the flexible platform 350 will be relatively light.
  • An advantage of this is that the flexible platform 350 can be easily held in place to a region of the user, such as the user's lower back, with or without a strap 410 .
  • the electrodes 60 have an electroconductive substance, shown generally by reference numeral 400 in FIG. 8, which increases the electroconductivity of the electrodes 60 to the skin of the user.
  • the electroconductive substance 400 can be any substance which performs this function, but in a preferred embodiment, the electroconductive substance 400 also has adhesive qualities which can assist in keeping the flexible platform 350 , which may have relatively little mass, in place on a surface of the user.
  • the electroconductive substance 400 can also assist in keeping individual electrodes 60 in contact with the surface of the user. It is understood that while the electroconductive substance 400 is shown as covering only four electrodes 60 in FIG. 8, preferably, the electroconductive substance 400 would be applied to all of the electrodes 60 .
  • electroconductive substances 400 While there are a number of electroconductive substances 400 which may be used, it has been found that Hydragel (trade mark) manufactured by Hydramar has worked well in experiments. In particular, the Hydragel electroconductive substance 400 increases the electric conductivity of the electrical therapeutic signals from the electrodes 60 to the skin of the user, and also, has sufficient adhesive quality to maintain the flexible platform 350 to the surface of the user. After a number of uses, however, the electroconductive substance 400 will lose its electroconductive qualities, and may also lose its adhesive qualities. In this case, the flexible platform 350 may simply be replaced with a new electroconductive substance 400 having the electroconductive substance 400 applied thereon. In the alternative, the flexible platform 350 may be recycled, such as by being cleaned and a fresh electroconductive substance 400 being applied onto the electrodes 60 .
  • the therapeutic electrical signals will have any type of voltage or current required to produce a therapeutic effect as persons skilled in the art may select. More particularly, while the present invention has been described with respect to therapeutic electrical signals having a base wave b w of a particular voltage, it is understood that the present invention is not limited to therapeutic electrical signals having this particular voltage, but rather would include any voltage that would produce therapeutic effects.
  • the present invention may be used for different types of therapies, including relief of pain, relief of stress, electronic acupuncture and transcutaneous electrical nerve stimulation (TENS), and, the precise voltage and current of the base wave b w of the therapeutic electrical signals for each of these therapies may differ.
  • an electroconductive cream should preferably be applied to the surface of the user to improve the electrical contact between the plurality of electrodes 60 and the user, thereby decreasing contact resistance.

Abstract

An apparatus, for providing therapeutic electrical signals has a plurality of sets of electrodes, each set of electrodes comprising at least two electrodes for applying the therapeutic electrical signal to a user. The electrodes (60) are arranged on a flexible platform (50) which can substantially conform to surfaces of the user. In one embodiment, the sets of electrodes (60) comprise at least three electrodes arranged in a substantially chevron pattern with a centre electrode having the opposite potential to the side electrode. Different types of therapeutic electrical signals are generated by a signal generator (24) applying a base wave within a frequency of about 150 KHz to 180 KHz at different frequencies between about 2 to 100 times in a second. A switch selectively switches the different types of therapeutic electrical signals in the predetermined pattern and can decrease the therapeutic electrical signals from its maximum to its minimum within about 0.1 to 0.01 microseconds.

Description

    FIELD OF THE INVENTION
  • This invention relates to a method and apparatus for use in electromedical therapy. More particularly, the present invention relates to a method and apparatus for applying a therapeutic electrical signal to regions of a user's body. The therapeutic signal could be used for any type of therapy, including to relieve pain, to relieve stress, to apply electronic acupuncture and for transcutaneous electrical nerve stimulation (TENS). [0001]
  • BACKGROUND OF THE INVENTION
  • In the past, several types of methods and apparatuses to apply an electrical signal in electromedical therapy have been used. However, the prior art methods and apparatuses generally provide a small number of electrodes to which the therapeutic electrical signal can be applied. This limits the area of the user's body to which the therapeutic signals can be applied at any one time. As a result, the duration of therapy and use of the apparatus by the user increase. [0002]
  • Furthermore, use of a small number of electrodes results in the electrical signal being applied to the same area for an extended period of time. This has been shown to create habituation effects. Habituation effects generally result from the body filtering out the therapeutic electrical signals being applied, thereby eliminating the positive effects of the therapeutic electrical signal. In addition, any benefit from the prior art device is usually limited to the time the therapeutic signals are applied, and does not provide any lingering effects. [0003]
  • U.S. Pat. No. 3,851,651 to Icenbice, Jr. discloses an electrical facial stimulator having eight individual electrodes in total attached to different parts of the face. The electrodes are energized to electrically stimulate the user's facial nerves and muscles. The facial stimulator of Icenbice, accordingly, provides a small number of electrodes which can be energized at a small and specific part of the user's body, namely specific parts of the face. [0004]
  • Likewise, U.S. Pat. No. 5,527,357 to Springer discloses a mask having a rigid outer lining providing the required structural integrity to hold about ten electrodes at specific locations over the face. The electrodes provide electrical signals to ten specific critical points on the face. Accordingly, Springer also suffers from the disadvantage that the mask provides a relatively small number of electrodes which provide electrical signals to a small and specific part of the user's face. [0005]
  • Use of a small number of electrodes, such as in prior art devices, requires the prior art devices to be periodically moved over the user's body. In fact, some prior art devices have electrodes which can rotate to facilitate movement over the user's body. However, these prior art devices are generally difficult for users to use on themselves and require a therapist or assistant to apply the treatment. This is especially the case where the treatment is being applied to the user's back, and particularly the lower back, which is not easily accessible by the user. [0006]
  • Furthermore, the prior art devices by and large generate an electrical signal which could itself harm the user and/or cause pain. This results from the electrical signal having characteristics that damage the skin surface and otherwise hurt the patient or cause the patient discomfort. While the beneficial effects of the electrical signal often outweigh the temporary discomfort of the patient, this discomfort sometimes causes patients not to use the prior art electromedical apparatuses, or not use them as frequently as required in order to provide effective long-term therapy. [0007]
  • Accordingly, the prior art devices suffer from several disadvantages. One of these disadvantages include that the prior art devices generally only apply the electrical signal to a small region of the body at one time. Another disadvantage is that the prior art devices often require an assistant to apply the therapy. Another disadvantage is that the therapeutic effects of the prior art devices are limited by the corresponding habituative effects caused by the patient's own body. A further disadvantage is that the electrical signals applied by the prior art devices often cause pain, burns and/or other discomfort to the patient because of the nature and the shape of the electrical signal being applied. A still further disadvantage of the prior art devices is that their beneficial effects are limited to the duration of the procedure, and do not provide any lingering beneficial effects which continue after the procedure is completed. [0008]
  • SUMMARY OF THE INVENTION
  • Accordingly, it is an object of this invention to at least partially overcome the disadvantages of the prior art. Also, it is an object of this invention to provide an improved apparatus and method for providing therapeutic electrical signals. [0009]
  • Accordingly, in one of its objects, this invention resides in an apparatus for providing therapeutic electrical signals, said apparatus comprising: a signal generator for generating the therapeutic electrical signal; a plurality of sets of electrodes, each set of electrodes comprising at least two electrodes for applying the therapeutic electrical signal to a user; and a switching unit for selectively switching the therapeutic electrical signal to each set of electrodes in a predetermined pattern. [0010]
  • In a further aspect, the present invention resides in a method for providing therapeutic electrical signals, said method comprising the steps of: (a)generating a therapeutic electrical signal; (b) providing a plurality of sets of electrodes, each set of electrodes comprising at least two electrodes for applying the therapeutic electrical signal to a user; and (c) selectively switching the therapeutic electrical signal to each set of electrodes of the plurality of sets of electrodes in a predetermined pattern. [0011]
  • Accordingly, one advantage of the present invention is that a plurality of sets of electrodes are used to apply the therapeutic electrical signal. In this way, a large surface of the user can be treated at any one time without the need to move the apparatus over the user's body. This makes it easier to apply the therapeutic electrical signal to the user. Furthermore, this makes it easier for the user to use the apparatus on themselves without an assistant. [0012]
  • In a preferred embodiment, the electrodes are arranged on a platform which permits electrodes to substantially conform to the surface of the user. This facilitates application of the therapeutic electrical signal to surfaces of regions of the user's body which are not generally flat. For example, this permits the platform to conform to variations in the user's back, such as around the spine. This also facilitates application of the therapeutic electrical signal to the lower back of the patient, such as along the acupuncture meridian, which may result in release of enkefalins by the body to relieve stress. [0013]
  • In a still further preferred embodiment, the present invention provides a flexible platform upon which the electrodes are contained. In this way, the entire platform, including the electrodes, can substantially conform to the surface of the user for improving the contact of the electrodes to the surface or skin of the user. In one embodiment, the flexible platform is separate and remote from the control unit to decrease the mass of the flexible platform and make it easier to apply and/or strap to the body. [0014]
  • A further advantage of the present invention is that it comprises a plurality of sets of electrodes to which the therapeutic electrical signal is applied in a predetermined pattern. Accordingly, while a large number of electrodes are available to be used in order to cover a large surface area of the user, the therapeutic electrical signal is only applied to a set of electrodes at any one time. In this way, the therapeutic electrical signal may be applied to electrodes proximate each other, permitting the therapeutic electrical signal to have a smaller electrical potential than would be required if the electrodes were distant from each other. Furthermore, this permits the switch to apply the therapeutic electrical signals in a predetermined pattern to achieve the best coverage and therapeutic benefit to the user. For example, in a preferred embodiment, the switch will apply the therapeutic electrical signal to a next set of electrodes in the plurality of electrodes every 0.5 to 2 seconds in order to avoid habituative effects. [0015]
  • A still further advantage of the present invention is that the therapeutic electrical signals can be applied to the sets of electrodes in a predetermined pattern. In this way, the user can control how the therapeutic electrical signals are applied, including the area, duration and type of therapeutic signal. Preferably, the predetermined pattern will be selected so as to decrease the habituation effect. The predetermined pattern can also be selected to provide lingering beneficial effects that continue after the procedure is completed. This can result, for example, by selecting a predetermined pattern that promotes generation of endorphins that are retained in the body. Furthermore, when the therapeutic electrical signal is applied to the acupuncture meridian, the body may generate enkefalins which will relieve stress. In addition, by applying the therapeutic electrical signal in a predetermined pattern as opposed to a random pattern, the user can be ensured that the therapeutic electrical signal will not be applied to the same set of electrodes consecutively. Applying the therapeutic electrical signal to the same set of electrodes consecutively could result in overexposure of the therapeutic electrical signals to a particular region of the user's body that may cause discomfort to the patient and/or promote habituation effects. [0016]
  • A further advantage of the present invention is that the therapeutic electrical signal can have characteristics which may decrease or eliminate pain while maintaining an effective therapeutic level. This is accomplished, in part, by the therapeutic electrical signal comprising a base wave having a relatively high frequency of about 150 KHz to 180 KHz and more preferably 160 to 170 KHz and the base wave is preferably applied about 2 to 100 times per second. To further decrease pain that may be associated with the therapeutic electrical signals, the base wave of the therapeutic electrical signal preferably decreases from its maximum to its minimum in about 0.2 to 0.01 microseconds. In a further preferred embodiment, the integral of the base wave over a cycle is zero. [0017]
  • A still further advantage of the present invention is that the predetermined pattern may comprise different types of therapeutic electrical signals. In other words, the switching unit will selectively switch between different types of therapeutic electrical signals to each set of electrodes in a predetermined pattern. In this way, the patient will be exposed to different types of therapeutic electrical signals that may have different beneficial effects. In addition, by changing the types of therapeutic electrical signals being applied, the habituation effects may also decrease. In this way, changing the types of therapeutic electrical signals, as well as limiting the duration that the switch may apply the therapeutic electrical signal to each set of electrodes to about 0.5 to 2 seconds, reduces the effects of the brain filters thereby reducing habituation effects, and may cause lingering beneficial effects which continue after the therapy is completed. [0018]
  • A further advantage of the present invention is that an electroconductive substance can be applied to the electrodes to increase electroconductivity. Because the electrodes tend to be stationary, the electroconductive substance will remain between the skin or surface of the user and the electrodes. Further, such electroconductive substance generally have the consistency of a gel which gives them an adhesive quality. In this way, the electroconductive substance can assist in keeping the electrodes in contact with the skin. Furthermore, in the case when the platform does not have a great deal of mass, such as when a flexible platform is used, the adhesive qualities of the electroconductive substance may be sufficient to maintain the flexible platform in place, especially flexible platform embodiment. [0019]
  • Further aspects of the invention will become apparent upon reading the following detailed description and drawings which illustrate the invention and preferred embodiments of the invention.[0020]
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • In the drawings, which illustrate embodiments of the invention: [0021]
  • FIGS. 1A and 1B are bottom and side views, respectively, of a device according to one embodiment of the present invention; [0022]
  • FIG. 2 is a schematic diagram showing the components of the apparatus for applying the therapeutic electrical signal; [0023]
  • FIG. 3 is a bottom elevation view of the device according to one embodiment of the present invention; [0024]
  • FIG. 4 is a timing diagram showing the base wave according to one embodiment of the present invention; [0025]
  • FIGS. 5A, 5B and [0026] 5C are timing diagrams showing different types of therapeutic electrical signals that may be applied in a predetermined pattern according to one embodiment of the present invention;
  • FIG. 6 is a perspective view of a device according to a further embodiment of the present invention having a housing separated from the platform; [0027]
  • FIG. 7A is a top view of an upper part of the flexible platform; [0028]
  • FIG. 7B is a bottom view of the lower part of the flexible platform; and [0029]
  • FIG. 8 is a diagram of an assembled flexible platform showing the wiring for the electrodes.[0030]
  • DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS
  • FIG. 1A is a bottom elevation view and FIG. 1B is a side elevation view of an apparatus, shown generally by [0031] reference numeral 10, for providing therapeutic electrical signals according to one embodiment of the present invention. As shown in FIGS. 1A and 1B, the apparatus 10 comprises a housing 12 which, in this embodiment, houses the plurality of electrodes 60. The housing 12 also houses other components, including input/output devices, such as a keypad and LEDs 16, as well as a power source, such as battery pack 8. The housing 12 preferably has an opening 112 for straps 114. In this way, the apparatus 10 can be strapped or fastened to a part of the user, such as the lower back or a leg, with straps 114.
  • In a preferred embodiment, the plurality of [0032] electrodes 60 are mounted on a platform 50 that permits relative movement of the electrodes 60. In this way, the platform 50 and/or the plurality of electrodes 60 on the platform 50 will be able to substantially conform to a surface of the user so that each of the plurality of electrodes 60 is in contact with a surface of the user, even if the surface of the user is not a flat surface. For example, the platform 50 may be flexible to permit the electrodes to substantially conform to the surface of the body. In one preferred embodiment, shown in FIGS. 7A, 7B and 8 and discussed more fully below, the platform 50 is made from a flexible, non-conductive material, such as rubber or mylar, which permits the plurality of electrodes 60 to substantially conform to a surface of the user and also electrically insulates the plurality of electrodes 60 from each other. In the alternative, the plurality of electrodes 60 could move relative to the platform 50, but be biased outwards so as to substantially conform to the surface of the patient. In either case, it is apparent that the platform 50 would permit the plurality of electrodes 60 to substantially conform to a surface of the user.
  • As also shown in FIG. 1A, the plurality of [0033] electrodes 60 preferably comprise nipples 61. The plurality of electrodes 60 may comprise at least one, and preferably more, nipples 61 to assist in decreasing the electrical contact resistance between the plurality of electrodes 60 and the surface of the user. In the preferred embodiment, shown in FIG. 1A, each electrode 60 has nine nipples 61.
  • FIG. 2 is a schematic diagram symbolically showing the components of the [0034] apparatus 10 for applying the therapeutic electrical signal according to one embodiment. As shown in FIG. 2, the apparatus 10 comprises input/output devices, such as a keypad and LEDs 16, as well as a power source, such as a battery pack 8, which are also illustrated in FIGS. 1A and 1B. As illustrated in FIG. 2, the apparatus 10 can also comprise a wall mount adapter 18 and a power supply and trickle charger 20, which together form a power unit to both supply power to the apparatus 10 and charge the battery pack 8 for later use.
  • The power supply and [0035] trickle charger 20 is connected to the keypad and LED 16 to supply power to this component. The keypad and LED 16, together with the power supply and trickle charger 20, are connected to the signal timing generator 22 to both supply power to the signal timing generator 22 and also send and receive input/output signals from the keypad and LED 16. Preferably, the keypad and LED 16 can send and receive input/output signals to the signal timing generator 22 which specify predetermined patterns and types of therapeutic electrical signals which should be applied to the plurality of electrodes 60 and which predetermined patterns are being applied.
  • In a preferred embodiment, the [0036] signal timing generator 22 comprises a microcontroller, such as a microprocessor. The signal timing generator 22 is connected to a plurality of switches 26. The signal timing generator 22 actuates the plurality of switches 26 to selectively switch the therapeutic electrical signal to the plurality of electrodes 60. The plurality of electrodes 60 are grouped into a plurality of sets of electrodes 60 a to 60 t. The switches 26 selectively switch the therapeutic electrical signal to each of the sets of electrodes 60 a to 60 t in a predetermined pattern.
  • As shown in FIG. 2, the first group of [0037] switches 26 a switch the therapeutic electrical signal to the first set 60 a of the plurality of sets of electrodes 60 a to 60 t. The first set of electrodes 60 a, in this embodiment, comprises the outer electrode pair no. 1 and the common electrode no. 1. Accordingly, in this embodiment, the first set of electrodes 60 a comprises three electrodes, namely a common electrode in the centre and a pair of outer electrodes. As also shown in FIG. 2, the apparatus 10 comprises a 20th set of electrodes 60 t comprising outer electrode pair no. 20 and common electrode no. 20. Therefore, the 20th set of electrodes 60 t also comprises three electrodes with a common electrode in the centre and a pair of outer electrodes. The signal timing generator 22 switches the therapeutic electrical signal to the 20th set of electrodes 60 t by actuating the 20th group of switches 26 t. While not shown in FIG. 2, it is apparent that the plurality of switches 26 would comprise switches 26 b to 26 s to switch the therapeutic electrical signal to each set of electrodes 60 b to 60 s.
  • In the embodiment shown in FIG. 2, there are 20 sets of electrodes comprising three electrodes for a total of 60 electrodes. However, it is understood that different sets of electrodes and different numbers of electrodes in each set can be used. [0038]
  • Together, the [0039] signal timing generator 22 and the plurality of switches 26 form the switching unit, shown generally by reference numeral 25. The switching unit 25 is used to send the therapeutic electrical signals selectively to each of the plurality of sets of electrodes 60 a to 60 t in a predetermined pattern.
  • The therapeutic electrical signal is generated by the [0040] signal generator 24. The signal, generator 24 will generate a base signal or base wave bw that is then selectively switched by the switching unit 25 to each one of the plurality of sets of electrodes 60 a to 60 t. The signal generator 24 is connected to the signal timing generator 22 to control the base wave bw so as to produce the predetermined pattern and control the type of therapeutic electrical signal being generated. The signal generator 24 is also connected to a power source, which in this embodiment is the battery pack 8, to draw sufficient power to generate the therapeutic electrical signal and the base wave bw that forms the therapeutic electrical signal.
  • In a preferred embodiment, the base wave b[0041] w will have a wave form shown in FIG. 4 by reference numeral bw. In a preferred embodiment, the base wave bw will have a frequency of between 150 KHz to 180 KHz, and more preferably 160 KHz to 170 KHz. In the preferred embodiment shown in FIG. 4, the base wave bw has a frequency of about 166 KHz.
  • At a frequency of 166 KHz, the period of the base wave b[0042] w will be about 6 microseconds. Preferably, the base wave bw will decrease quickly from its maximum to its minimum. For example, as shown in FIG. 4, the base wave bw will decrease from its maximum value bmax of about positive 50V to its minimum value bmin of about negative 17V in a time t which preferably is within about 0.2 to 0.01 microseconds and still more preferably within about 0.1 to 0.01 microseconds. In a preferred embodiment, the time t is most preferable about 0.05 microseconds. By having the base wave bw decrease from the maximum bmax to its minimum bmin within this relatively short time period, it has been found that the pain, burns, and other discomfort felt by the patient is greatly decreased.
  • From analysis of the base wave b[0043] w shown in FIG. 4, it is also apparent that the integral of the base wave bw over time will be zero. This is apparent from FIG. 4 which illustrates that the Area A between bmax and zero is approximately equal to the Area B between bmin and zero. This is the case because the value bmax is about positive 50V and lasts for a duration of 1.5 microseconds while the voltage bmin is about a third of that, namely negative 17V, but lasts for three times as long, namely about 4.5 microseconds. Accordingly, Area A is substantially equal to Area B, which illustrates that the integral of the base wave bw over time will be zero. This also illustrates that the net charge imposed on the user by each electrode over a period of the base wave bw will always be zero. As the therapeutic electrical signal comprises the base wave bw, the integral over time of the therapeutic electrical signal will also be zero. It has been found that by having a base wave bw, and therefore a therapeutic electrical signal, with an integral over time of about zero, the overall pain, burns and discomfort suffered by the patient greatly decreases.
  • As stated above, the therapeutic electrical signal comprises the base wave b[0044] w. However, it is preferred that the therapeutic electrical signal is not identical to the base wave bw. Rather, it is preferred that the therapeutic electrical signal comprises bursts of the base wave bw. In other words, the therapeutic electrical signal preferably comprises bursts of the base wave bw at specific frequencies, such as 2 to 100 times in a second, and the base wave bw would be quiet or not applied at other times.
  • FIG. 5A shows a first therapeutic electrical signal tes[0045] a where the base wave bw is applied four times in a second. Therefore, the first therapeutic electrical signal tesa has a period of about 250 milliseconds and a frequency of 4 Hz. During the period of 250 milliseconds, the base wave bw is applied for about half that time, or 125 milliseconds. For the remaining period, namely 125 milliseconds, the base wave bw is not applied.
  • FIG. 5B shows a second therapeutic electrical signal tes[0046] b where the base wave bw is applied two times in a second. The second therapeutic electrical signal tesb is applied in a burst of about 250 milliseconds and then is quiet or not applied for about 250 milliseconds. Accordingly, the second therapeutic electrical signal tesb has a period of about 500 milliseconds and a frequency of about 2 Hz.
  • FIG. 5C shows a third therapeutic electrical signal tes[0047] c that has a period of about 13 milliseconds, and therefore a frequency of about 77 Hz. In this embodiment, the base wave bw is applied for a burst of about 3 milliseconds followed by a quiet period where the base wave bw is not applied for about 10 milliseconds. In this way, the third electrical signal tesc applies the base wave bw 77 times in a second, but for only about 3 milliseconds each time.
  • The [0048] apparatus 10 can apply any of the therapeutic electrical signal tesa, tesb, tesc, or any other type of therapeutic electrical signal. In a preferred embodiment, the therapeutic electrical signal will comprise a base wave bw applied at a frequency of about 2 to 100 times per second. As shown in FIGS. 5A, 5B and 5C, the duration or burst during which the base wave bw is applied can vary and may not correspond to half of the period, as illustrated by the third therapeutic electrical signal tesc in FIG. 5C. Furthermore, the predetermined pattern of the apparatus 10 may comprise different types of therapeutic electrical signals, as described more fully below.
  • FIG. 3 shows the bottom elevation of the [0049] apparatus 10, similar to the view shown in FIG. 1A. In a preferred embodiment as illustrated in FIG. 3, each of the plurality of sets of electrodes 60 a to 60 t comprise at least three electrodes 60 arranged in a substantially chevron pattern. For example, the first set of electrodes 60 a shown in FIG. 3 comprise electrodes 1, 2 and 3. Likewise, the last set of electrodes 60 t comprise electrodes 4, 5 and 6. It is apparent that the twenty chevron patterns between the first set of electrodes 60 a and the last set of electrodes 60 t illustrate each set of the plurality of sets of electrodes 60 a to 60 t of the embodiment illustrated in FIG. 3.
  • It is preferable that the centre electrode, such as [0050] electrodes 2 and 5, of the plurality of sets of electrodes 60 a to 60 t, have a potential that is opposite to the potential of the side electrodes 1, 3 and 4, 6. To accomplish this, centre electrodes 2, 5 may have different electrical switches 26 from the side electrodes. This is illustrated in FIG. 2 where the first group of switches 26 a comprise switches 26 ao and 26 ac. Switch 26 ao actuates the outer electrode pair no. 1 corresponding to electrodes 1 and 3 and switch 26 ac actuates the common electrode no. 1 corresponding to electrode 2. Likewise, the 20th group of switches 26 comprise switches 26 tc and 26 to. Switch 26 th actuates the outer electrode pair no. 20 corresponding to electrodes 4 and 6 and switch 26 tc actuates the common electrode no. 20 corresponding to electrode 5.
  • It is understood that the chevron pattern of electrodes illustrated in FIG. 3 is a preferred embodiment and is selected to permit a relatively large area to be effected by the therapeutic electrical signal, while at the same time having the electrodes fairly near each other so that the voltage may not be too large to overcome the natural resistance of the body. Nevertheless, it is understood that other arrangements of electrodes, other than a chevron pattern, including a square pattern, a circular or semi-circular pattern or even a straight line, could be used provided each set of electrodes [0051] 60 a to 60 t have at least two electrodes through which the therapeutic electrical signal may pass.
  • In the embodiment shown in FIG. 3 where a chevron pattern is used, it is apparent that not all of the plurality of [0052] electrodes 60 will have an electrical signal passing through them. For example, electrodes a, b, c, d, e, f do not form a chevron pattern with other electrodes, and therefore would not be used in the embodiment shown in FIG. 3. However, if another pattern, such as a straight line is used, then electrodes a, b, c, d, e, f may have electrical signal passing through them.
  • As stated above, the switching [0053] unit 25 will apply the therapeutic electrical signal to the plurality of sets of electrodes 60 a to 60 t in the predetermined pattern. The predetermined pattern may be any pattern that switches the therapeutic electrical signal to each set of electrodes 60 a to 60 t in a controlled manner without causing the therapeutic electrical signal to be switched to the same set of electrodes twice, thereby causing habituation effects.
  • In a preferred embodiment, the switching [0054] unit 25 will send the therapeutic electrical signal sequentially to each set of electrodes 60 a to 60 t. For example, as shown in FIG. 3, the switching unit 25 will send the therapeutic electrical signal sequentially in a consecutive order commencing with the first set of electrodes 60 a at a first end 30 of the apparatus 10 and platform 50 and ending at the last set of electrodes 60 t at the second end 32 of the apparatus 10 and platform 50. The switching unit 25 may have a predetermined pattern which continuously and repeatedly sends the therapeutic electrical signal sequentially in this consecutive order from the first set of electrodes 60 a to the last set of electrodes 60 t. Alternatively, the switching unit 25 may have a predetermined pattern which sends the therapeutic electrical signal in alternate directions “sweeping” across the platform 50.
  • For example, as shown in FIG. 3, the switching [0055] unit 25 may first apply the therapeutic electrical signals in a first direction, shown generally by the arrows marked with reference numeral 41, from the first end 30 to the second end 32. The switching unit 25 may then apply the therapeutic electrical signal in a second direction, shown generally by the arrows marked with reference numeral 42, from the second end 32 to the first end 30. For present purposes, a sweep is considered to be an application of therapeutic electrical signals once across each of the sets of electrodes 60 a to 60 t in either direction 41, 42 “sweeping” across the platform 50.
  • In the embodiment illustrated in FIG. 3, the sets of electrodes [0056] 60 a to 60 t in the first direction 41 will be the same as the sets of electrodes 60 t to 60 a in the second direction 42. In other words, the therapeutic electrical signal will be applied to the same three electrodes in each set of electrodes 60 a to 60 t in both directions 41, 42. However, the present invention is not limited to this embodiment. Rather, the sets of electrodes 60 a to 60 t in the first direction 41 may differ from the sets of electrodes 60 a to 60 t in the second direction 42, provided there are at least two electrodes 60 in each set of electrodes 60 a to 60 t.
  • In addition, the therapeutic electrical signal need not be the same in each direction. Rather, in a preferred embodiment, the therapeutic electrical signal will change with each “sweep”. For example, as set out in Table A below, in [0057] sweep 1, which preferably is in a first direction 41, the therapeutic electrical signal will correspond to the first therapeutic electrical signal tesa shown in FIG. 5A and will be sequentially and consecutively applied to each of the plurality of sets of electrodes 60 a to 60 t. In sweep 2, which is preferably in the second direction 42, the therapeutic electrical signal will correspond to the second therapeutic electrical signal tesb illustrated in FIG. 5B. Likewise, in sweep 3, which is preferably in the first direction 41, the therapeutic electrical signal will correspond to the third therapeutic electrical signal tesc illustrated in FIG. 5C.
    TABLE A
    Bursts Bursts per Dura- Duration
    per sweep tion for each
    Pe- sets of (20 sets of of set of
    Quiet Burst riod elec- electrodes sweep electrodes
    Sweep (ms) (ms) (ms) trodes 60) (sec) (sec)
    1 125 125 250 4 80 20 1
    2 250 250 500 2 40 20 1
    3 10 3 13 77 154 20.02 1
  • One advantage of the above is that the application of the base wave b, at the different frequencies, namely 4 Hz, 2 Hz and 77 Hz, will have different beneficial effects to the patient. For example, a frequency of about 77 Hz has been found to generate endorphins, and enkefalins which tend to relieve stress, and therefore it is preferred for a pain killing effect. Generation of enkefalins have been found to be most pronounced when the [0058] apparatus 10 is applied to the acupuncture meridians along the lower back region. The frequencies of 2 Hz and 4 Hz have been found to generate endorphins.
  • Accordingly, the [0059] apparatus 10 can apply the therapeutic electrical signals to the sets of electrodes 60 a to 60 t in a predetermined pattern. In addition, the predetermined pattern of the apparatus 10 can comprise different types of therapeutic electrical signals tesa, teab, tesc at different stages.
  • It has been found that, preferably, the therapeutic electrical signal is applied to a set of electrodes [0060] 60 a to 60 t for about 0.5 to 2 seconds. For example, as illustrated in Table A above, the therapeutic electrical signals are applied to each set of electrodes 60 a to 60 t for a duration of about 1 second. In this way, as there are about 20 sets of electrodes in the embodiment shown in FIG. 3, each sweep from one end 30 or 32 to the other end 32 or 30 will take about 20 seconds. The predetermined pattern shown in Table A which comprises three sweeps and three types of therapeutic electrical signals tesa, tesb, tesc will therefore take about one minute. Preferably, the switch to a next set of electrodes 60 a to 60 t will occur during a quiet period when the base wave bw is not being applied.
  • The duration of 0.5 to 2 seconds is preferable because it is sufficient to generate endorphins and enkefalins. However, in addition, a duration of 0.5 to 2 seconds is generally insufficient to permit the body to generate hormones that counteract the beneficial effects of endorphins and enkefalins. Accordingly, by having the therapeutic electrical signals applied in a predetermined pattern where the switching [0061] unit 25 switches the therapeutic electrical signal to a next set of electrodes within 0.5 to 2 seconds, habituation effects may decrease and the user may experience a build-up of endorphins and enkefalins. In this way, the user may experience a lingering effect from use of the apparatus 10, at least in part because of the build-up of endorphins and enkefalins caused by the use of the apparatus 10.
  • Likewise, it has been found that by having a predetermined pattern that comprises different types of therapeutic electrical signals tes[0062] a, tesb, tesc, habituation effects may be further decreased because use of different types of therapeutic electrical signals tesa, tesb, tesc may bypass the brain filters which cause the habituation effects. Habituation effects have been found to be further decreased by applying the different types of therapeutic electrical signals tesa, tesb, tesc to the user for a duration of not more than 0.5 to 2 seconds per set of electrodes 60 a to 60 t. Moreover, applying different types of therapeutic electrical signals tesa, tesb, tesc will also produce different types of beneficial effects, such as generation of endorphins, as well as generation of enkefalins. Accordingly, generating and applying different types of therapeutic electrical signals, tesa, tesb, tesc across a plurality of electrodes 60 not only helps to decrease habituation effects, but also provides more than one type of benefit to the user, and, the benefit the user may experience is more likely to linger after use of the apparatus 10 has ceased.
  • FIG. 6 shows an apparatus, shown generally by [0063] reference numeral 300, accordingly a further embodiment of the present invention. As shown in FIG. 6, the apparatus 300 has a platform which is separate from a housing 310 which houses other components of the apparatus 300, such as the signal generator 24 and switching unit 25. As illustrated in FIG. 6, the housing 310 may also include input/output such as the keypad and LED 306. The housing 310 will also preferably contain a power supply and trickle charger 20 to supply a battery pack 8 and/or receive power from a wall mount adapter 18, similar to the apparatus 10 described above.
  • As also illustrated in FIG. 6, the [0064] housing 310 is connected to the platform 50 by an electrical connection, shown generally by reference numeral 313. The electrical connection 313 in this embodiment comprises a first fixed electrical cable 312 from the housing 310 to a connector, such as an oyster connector 316. The first cable 312 is generally fixed to both the housing 310 at one end 311 and fixed to the connector 316 at the second end 318. In this way, the connector 316 is electrically connected to the components of the apparatus 300, including the signal generator 24. The connector 316 shown in FIG. 6 is commonly referred to as an “oyster” connector, but it is understood that any type of connector can be used.
  • The [0065] connector 316 also comprises an input/output slot 319 which can releasably receive a first end 419 (shown in FIGS. 7A, 7B and 8) of a second removable cable 314. The second end 420 (shown in FIGS. 7A, 7B and 8) of the second cable 314 is connected, generally permanently to the platform 50 providing an electrical connection from the first end 419 of the second cable 314 to the electrodes 60 on the platform 50. In this way, the first end 419 of the second cable 314 may be releasably mated or received into the input/output slot 319 of the connector 316 to thereby releasably electively connect the components contained within the housing 310, and in particular, the signal generator 24, to the electrodes 60 on the platform 50. In another embodiment, the connector 316 is integrally formed as part of the housing 310 such that the first fixed cable 312 is not needed, but rather the first end 419 of the second cable 314 would be releasably received in an input/output slot 319 in the housing 310.
  • The advantages of the [0066] apparatus 300 shown in FIG. 6 include that the platform 50 can be removed from the connector 316 for maintenance and/or servicing. Furthermore, in a preferred embodiment, different types of platforms 50, either having different size or different arrangements of electrodes 60 thereon, may be interchangeably releasably received into the slot 319 of the connector 316. This gives the apparatus 300 shown in FIG. 6 increased versatility.
  • Furthermore, in a preferred embodiment, the [0067] platform 50 may be a flexible platform 350, shown in FIG. 6, but illustrated and discussed below in more detail with respect to FIGS. 7A, 7B and 8. In the case of flexible platforms 350, they are generally disposable such that after a number of uses, the first end 419 of the second cable 314 may be releasably removed from the slot 319 of the connector 316 and replaced with the first end 419 of another second cable 314 connected to another flexible platform (not shown). In this way, flexible platforms 350, which are generally less resilient, may be replaced periodically and either disposed of or recycled.
  • FIGS. 7A and 7B show a [0068] flexible platform 350 according to a preferred embodiment of the present invention. FIG. 7A shows the top view of the upper part of the flexible platform 350U. The upper part of the flexible platform 350U includes silver inking connectors 370 extending along the second cable 314 to the first end 419. The silver inking connectors 370 are electrically conductive and can conduct the therapeutic electrical signals received from the signal generator 24 through the switches 26, the first cable 312, the connector 316 and the second cable 314. In this preferred embodiment, illustrated in FIG. 6, the second cable 314 is integrally formed with the flexible platform 350 such that the silver inking connectors 370 will extend past the second end 420 to connections 340. However, it is understood that the second cable 314 may be separate from the flexible platform 350 so that a further connector (not shown) would be present to connect the second end 420 of the second cable 314 to the flexible platform 350.
  • The [0069] connections 340 are electrically connected to the centre electrodes 60 c shown as the middle row of the three rows of electrodes 60 in FIG. 7B. The centre electrodes 60 c are actuated by the centre switches 26 ac to 26 tc as discussed above with respect to FIGS. 2, 3, 4 and 5. In this way, the therapeutic electrical signals can be transmitted from the signal generator 24 to the centre electrodes 60 c.
  • FIG. 7B, which shows the lower part of the [0070] flexible platform 350L, likewise has silver inking connectors 371 extending along the second cable 314 to the first end 419 to receive the electrical therapeutic signal from the signal generator 24, similar to the silver inking connectors 370. However, the silver inking connectors 371 in the lower part of the flexible platform 350L extend to the outer electrodes 60 o shown at the two external rows in FIG. 7B. The outer electrodes 60 o are actuated by the outer switches 26 ao to 26 to discussed above with respect to FIGS. 2, 3, 4 and 5.
  • It is apparent from FIGS. 7A and 7B that the [0071] silver inking connectors 370 on the upper part of the flexible platform 350U will be electrically insulated from the silver inking connectors 371 on the lower part of the flexible platform 350L. It is also apparent that while electrodes 60 are all present on the lower part of the flexible platform 350L, the middle row will be electrically insulated from the outer two rows, except for electrical contact through the surface of the user through which therapeutic electrical signals will flow.
  • Preferably, the upper and lower parts of the [0072] flexible platform 350U and 350L, respectively, are manufactured from an insulated material upon which the silver inking connectors 370, 371 may be applied. In a preferred embodiment, the upper and lower parts of the flexible platforms 350U and 350L, respectively, are manufactured from portions of mylar, but other substances, such as rubber, plastics, or other electrically insulated materials, could also be used.
  • As shown in FIG. 7B, the [0073] electrodes 60 will have an orientation such as a chevron, shown generally by reference numeral 365. In this way, the therapeutic electrical signal 60 will be applied along a chevron pattern, similar to that as discussed above with respect to the apparatus 10. In other words, the electrodes 60 on the flexible platform 350 can be used in the same manner as the electrodes 60 on the apparatus 10 discussed above.
  • FIG. 8 shows the [0074] flexible platform 350 in the assembled position with the upper part 350U connected to the lower part 350L such as by gluing, laminating or otherwise connecting the upper part 350U to the lower part 350L. As illustrated in FIG. 8, the silver inking connectors 370, 371 overlap, but are electrically insulated. For instance, if the silver inking connectors 370 are on the upper surface 361 of the upper part of the flexible platform 350L and the silver inking connectors 371 are on the lower surface 362 of the lower part of the flexible platform 350L, then the upper and lower parts 350U, 350L, respectively, of the flexible platform 350 will act as the electrical insulation. This is the case because the silver inking connectors 370 are on the upper surface 361 of the flexible platform 350 and the silver inking connectors 371 are on the lower surface 362 of the flexible platform 350 when the parts 350U, 350L are assembled. It will be appreciated by persons skilled in the art that the same effect could be obtained by having a flexible platform 350 manufactured from a single layer of mylar, or other electrically insulative substance with the silver inking connectors 370 on the upper surface 361 and the silver inking connectors 371 on the lower surface 362, rather than having two parts 350U, 350L connected together.
  • As shown in FIG. 8, the [0075] flexible platform 350 may also comprise a strap 410. The strap 410 can be integrally formed with the flexible platform 350. The strap 410 can be used to strap the flexible platform 350 to a region of the user, such as an arm or leg. The strap 410 may also be wrapped around the connector 316 to assist in holding the first end 419 of the second cable 314 to the cable 316.
  • It is also understood that the [0076] flexible platform 350, with the present construction, will be relatively light. An advantage of this is that the flexible platform 350 can be easily held in place to a region of the user, such as the user's lower back, with or without a strap 410.
  • In a further preferred embodiment, the [0077] electrodes 60 have an electroconductive substance, shown generally by reference numeral 400 in FIG. 8, which increases the electroconductivity of the electrodes 60 to the skin of the user. The electroconductive substance 400 can be any substance which performs this function, but in a preferred embodiment, the electroconductive substance 400 also has adhesive qualities which can assist in keeping the flexible platform 350, which may have relatively little mass, in place on a surface of the user. The electroconductive substance 400 can also assist in keeping individual electrodes 60 in contact with the surface of the user. It is understood that while the electroconductive substance 400 is shown as covering only four electrodes 60 in FIG. 8, preferably, the electroconductive substance 400 would be applied to all of the electrodes 60.
  • While there are a number of [0078] electroconductive substances 400 which may be used, it has been found that Hydragel (trade mark) manufactured by Hydramar has worked well in experiments. In particular, the Hydragel electroconductive substance 400 increases the electric conductivity of the electrical therapeutic signals from the electrodes 60 to the skin of the user, and also, has sufficient adhesive quality to maintain the flexible platform 350 to the surface of the user. After a number of uses, however, the electroconductive substance 400 will lose its electroconductive qualities, and may also lose its adhesive qualities. In this case, the flexible platform 350 may simply be replaced with a new electroconductive substance 400 having the electroconductive substance 400 applied thereon. In the alternative, the flexible platform 350 may be recycled, such as by being cleaned and a fresh electroconductive substance 400 being applied onto the electrodes 60.
  • It is clear that the therapeutic electrical signals will have any type of voltage or current required to produce a therapeutic effect as persons skilled in the art may select. More particularly, while the present invention has been described with respect to therapeutic electrical signals having a base wave b[0079] w of a particular voltage, it is understood that the present invention is not limited to therapeutic electrical signals having this particular voltage, but rather would include any voltage that would produce therapeutic effects. In addition, the present invention may be used for different types of therapies, including relief of pain, relief of stress, electronic acupuncture and transcutaneous electrical nerve stimulation (TENS), and, the precise voltage and current of the base wave bw of the therapeutic electrical signals for each of these therapies may differ. Preferably, an electroconductive cream, as is known in the art, should preferably be applied to the surface of the user to improve the electrical contact between the plurality of electrodes 60 and the user, thereby decreasing contact resistance.
  • In addition, while the present invention has been described with respect to three types of therapeutic electrical signals, tes[0080] a, tesb, tesc, it is understood that the invention is not restricted to these particular three types of therapeutic electrical signals. While these three types of therapeutic electrical signals tesa, tesb, tesc have been found to be preferred therapeutic electrical signals, other types of therapeutic electrical signals may also be used in the predetermined pattern of this invention.
  • It will be understood that, although various features of the invention have been described with respect to one or another of the embodiments of the invention, the various features and embodiments of the invention may be combined or used in conjunction with other features and embodiments of the invention as described and illustrated herein. [0081]
  • Although this disclosure has described and illustrated certain preferred embodiments of the invention, it is to be understood that the invention is not restricted to these particular embodiments. Rather, the invention includes all embodiments which are functional, mechanical or electrical equivalents of the specific embodiments and features that have been described and illustrated herein. [0082]

Claims (30)

The embodiments of the invention in which an exclusive property or privilege is claimed are defined as follows:
1. An apparatus (10, 300) for providing therapeutic electrical signals, said apparatus comprising:
signal generator means 24 for generating the therapeutic electrical signal;
a plurality of sets of electrodes (60 a to 60 t), each set of electrodes (60 a to 60 t) comprising at least two electrodes (60) for applying the therapeutic electrical signal to a user; and
switching means (26) for selectively switching the therapeutic electrical signal to each set of electrodes (60 a to 60 t) in a predetermined pattern characterized in that the predetermined pattern sequentially sends the therapeutic electrical signal in a first direction (41) from a first set of electrodes (60 a) to a last set of electrodes (60 t).
2. The apparatus (10, 300) as defined in claim 1 characterized in that:
the plurality of sets of electrodes (60 a to 60 t) are arranged on a platform (50, 350); and
wherein the platform (50, 350) permits the electrodes (60) to substantially conform to a surface of the user, such that the electrodes (60) of the plurality of sets of electrodes (60 a to 60 t) are in substantial electrical contact with a surface of the user.
3. The apparatus (10, 300) as defined in claim 2 characterized in that the predetermined pattern sends the therapeutic electrical signal consecutively to each set of electrodes (60 a to 60 t) commencing with the first set of electrodes (60 a) near a first end (30) of the platform (50, 350)and ending at a last set of electrodes (60 t) near a second end (32) of the platform (50, 350).
4. The apparatus (10, 300) as defined in claim 1 characterized in that the switching means (26) will switch the therapeutic electrical signal to a next set of electrodes (60 a to 60 t) in the predetermined pattern within 0.5 to 2 seconds.
5. The apparatus (10, 300) as defined in claim 4 characterized in that the signal generator means (24) generates more than one type of therapeutic electrical signal; and
the switching means (26) selectively switches different types of therapeutic electrical signals to each set of electrodes (60 a to 60 t) in a predetermined pattern.
6. The apparatus (10, 300) as defined in claim 1 characterized in that the predetermined pattern sequentially sends the electrical therapeutic signal in the first direction (41) consecutively commencing with a first set of electrodes (60 a) near a first end (30) of the apparatus and ending at a second set of electrodes (60 t) near a second end (32) of the apparatus and then send the electrical therapeutic signal in a second direction (42) consecutively commencing with a third set of electrodes (60 t) at the second end (32) to a fourth set of electrodes at the first end (30); and
wherein the sets of electrodes (60 a to 60 t) in the first direction (41) differ from the sets of electrodes (60 t to 60 a) in the second direction (42).
7. The apparatus (10, 300) as defined in claim 1 characterized in that the sets of electrodes (60 a to 60 t) comprise at least three electrodes (60) arranged in a substantially chevron pattern with at least a centre electrode (60 c) and at least two side electrodes (60 o); and
wherein the centre electrode (60 c) has a potential opposite to the side electrodes (60 o) when the therapeutic electrical signal is applied.
8. The apparatus (10, 300) as defined in claim 7 characterized in that the predetermined pattern comprises a first type of therapeutic electrical signal (tec a) and a second type of therapeutic electrical signal (tec b), said first type of therapeutic electrical signal (tec a) comprising a base wave (bw) applied at a first frequency and said second type of therapeutic electrical signal (tec b) comprising the base wave (bw) applied at a second frequency where the first frequency differs from the second frequency.
9. The apparatus (10, 300) as defined in claim 1 characterized in that the therapeutic electrical signals are used in therapy selected from a group of therapies consisting of relief of pain, relief of stress, electronic acupuncture and transcutaneous electrical nerve stimulation (TENS).
10. The apparatus (10, 300) as defined in claim 1 characterized in that the therapeutic electrical signals comprise a base wave (bw) having a frequency between 150 KHz to 180 KHz, said base wave (bw) being applied at a frequency of between about 2 to 100 times in a second.
11. The apparatus (10, 300) as defined in claim 10 characterized in that the switching means (25)will switch the therapeutic electrical signal to a next set of electrodes within 0.5 to 2 seconds.
12. The apparatus (10, 300) as defined in claim 11 characterized in that the base wave (bw) of the therapeutic electrical signals decreases from a maximum to a minimum within about 0.2 to 0.01 microseconds; and
wherein an integral against time of the base wave (bw) of the therapeutic electric signals over a complete cycle is substantially zero.
13. The apparatus (10, 300) as defined in claim 1 characterized in that the signal generator means (24) generates different types of therapeutic electrical signals by applying a base wave (bw) having a frequency between 150 KHz to 180 KHz at differing durations and at differing frequencies between 2 Hz to 100 Hz; and
wherein the switching means (25) selectively switches different types of therapeutic electrical signals to each set of electrodes (60 a to 60 t) in a predetermined pattern.
14. A method for providing therapeutic electrical signals, said method comprising the steps of:
a) generating a therapeutic electrical signal;
b) providing a plurality of sets of electrodes, each set of electrodes comprising at least two electrodes for applying the therapeutic electrical signal to a user; and
c) selectively switching the therapeutic electrical signal to each set of electrodes of the plurality of sets of electrodes in a predetermined pattern.
15. The method as defined in claim 14 further comprising the step of:
b1) providing the plurality of sets of electrodes on a platform that permits the electrodes to substantially conform to a surface of the user so that substantially all of the electrodes of the plurality of electrodes is in electrical contact with the surface of the user.
16. The method as defined in claim 15 further comprising the step of:
c1) selectively switching the therapeutic electrical signal to each set of electrodes consecutively commencing with a first set of electrodes near a first end of the platform and ending at a last set of electrodes at a second end of the platform.
17. The method as defined in claim 14 further comprising the step of:
b3) providing each set of electrodes with at least three electrodes arranged in a substantially chevron pattern having a centre electrode and at least two side electrodes.
18. The method as defined in claim 14 wherein the therapeutic electrical signals comprise a base wave having a frequency between 150 KHz to 180 KHz, said base wave being applied at a frequency of between about 2 to 100 times in a second.
19. The method as defined in claim 18, further comprising the step of:
c2) selectively switching the therapeutic electrical signal to each set of electrodes in intervals of between 0.5 and 2 seconds.
20. The method as defined in claim 19 wherein the base wave of the therapeutic electrical signal decreases from a maximum to a minimum within about 0.1 to 0.01 microseconds.
21. The method as defined in claim 20 wherein an integral against time of the base wave of the therapeutic electric signals over a complete cycle is substantially zero.
22. The method as defined in claim 14 further comprising the steps of:
a1) generating different types of therapeutic electrical signals by generating a base wave having a frequency between 150 KHz and 180 KHz and applying the base wave for differing durations and at different frequencies between 2 Hz to 100 Hz; and
c1) selectively switching different types of therapeutic electrical signals to each set of electrodes in a predetermined pattern.
23. The apparatus (10, 300) as defined in claim 1 characterized in that the predetermined pattern switches the therapeutic electrical signals to each set of electrodes (60 a to 60 t) in a controlled manner without causing the therapeutic electrical signal to be switched to the same set of electrodes twice.
24. The apparatus (300) as defined in claim 1 characterized in that the platform (350) upon which the electrodes (60) are arranged is flexible; and
wherein the flexible platform (350) can substantially conform to the region of the user such that the electrodes (60) of the plurality of sets of electrodes (60 a to 60 t) are in substantial electrical contact with the surface of the user.
25. The apparatus (300) as defined in claim 24 characterized by:
a housing (310) for containing the signal generator means (24) and the switching means (26); and
an electrical connection (313) from the housing (310) to the flexible platform for sending the therapeutic electrical signal from the housing (310) to the flexible platform (350) located an the surface of the user.
26. The apparatus (300) as defined in claim 25 characterized in that the electrical connection (313) comprises a connector (316) capable of releasably electrically connecting the signal generator means 24 in the housing (310) with the electrodes (60) on the flexible platform (350).
27. The apparatus as defined in claim 26 characterized in that the connector (316) is electrically connected to the signal generator means (24) in the housing (310) and can interchangeably releasably connect other electrodes (60) of other flexible platforms (350) to the signal generator means (24).
28. The apparatus as defined in claim 26 characterized in that the connector (316) is electrically connected to the signal generator means (24) in the housing (310); and
wherein the flexible platform (350) is disposable such that, after a number of uses, the flexible platform (350) can be electrically disconnected from the connector (316) and the connector (316) is capable of releasably electrically connecting the signal generator means (24) to the electrodes (60) of another flexible platform (350).
29. The apparatus as defined in claims 24 to 28 characterized by an electroconductive substance (400) having an adhesive quality can be applied to the electrodes (60) to improve electrical contact between the electrodes (60) and the surface of the user and assists in maintaining the flexible platform (350) in place on the surface of the user.
30. The apparatus as defined in claim 24 characterized in that the flexible platform (350) comprises a first surface (350U) containing first electrical conductors (370) connected to a first group (60 c) of the plurality of electrodes (60) and a second surface (350L) containing second electrical conductors (371) electrically connected to a second group (600) of the plurality of electrodes (60); and
wherein the first electrical conductors (370) and the first group of electrodes (60 c) are electrically insulated from the second electrical conductors (371) and the second group of electrodes (60 o).
US10/257,582 2000-04-12 2001-04-11 Method and apparatus for electromedical theraphy Abandoned US20030191506A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US10/257,582 US20030191506A1 (en) 2000-04-12 2001-04-11 Method and apparatus for electromedical theraphy

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US09548375 2000-04-12
US09/548,375 US6546290B1 (en) 2000-04-12 2000-04-12 Method and apparatus for electromedical therapy
US10/257,582 US20030191506A1 (en) 2000-04-12 2001-04-11 Method and apparatus for electromedical theraphy

Publications (1)

Publication Number Publication Date
US20030191506A1 true US20030191506A1 (en) 2003-10-09

Family

ID=24188588

Family Applications (2)

Application Number Title Priority Date Filing Date
US09/548,375 Expired - Fee Related US6546290B1 (en) 2000-04-12 2000-04-12 Method and apparatus for electromedical therapy
US10/257,582 Abandoned US20030191506A1 (en) 2000-04-12 2001-04-11 Method and apparatus for electromedical theraphy

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US09/548,375 Expired - Fee Related US6546290B1 (en) 2000-04-12 2000-04-12 Method and apparatus for electromedical therapy

Country Status (11)

Country Link
US (2) US6546290B1 (en)
EP (1) EP1282457B1 (en)
JP (1) JP2003530920A (en)
KR (1) KR20030003722A (en)
AT (1) ATE311926T1 (en)
AU (2) AU2001252069B2 (en)
CA (1) CA2405867A1 (en)
DE (1) DE60115633D1 (en)
EA (1) EA005742B1 (en)
IL (1) IL152223A0 (en)
WO (1) WO2001078834A1 (en)

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050209641A1 (en) * 2000-02-17 2005-09-22 Yoram Palti Treating a tumor or the like with an electric field
US20060149341A1 (en) * 2004-12-07 2006-07-06 Yoram Palti Electrodes for applying an electric field in-vivo over an extended period of time
US20060167499A1 (en) * 2000-02-17 2006-07-27 Standen Ltd Treating a tumor or the like with electric fields at different orientations
US20060233867A1 (en) * 2002-10-02 2006-10-19 Yoram Palti Article of clothing for treating a tumor or the like
US20070028310A1 (en) * 2002-10-02 2007-02-01 Yoram Palti Apparatus for selectively destroying dividing cells
WO2007039799A2 (en) * 2005-10-03 2007-04-12 Novocure Ltd. Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
WO2007096600A1 (en) * 2006-02-21 2007-08-30 Teodor Goroszniuk Improvements in and relating to neurostimulation
US20080221630A1 (en) * 2007-03-06 2008-09-11 Yoram Palti Treating cancer using electromagnetic fields in combination with photodynamic therapy
US20090043346A1 (en) * 2000-02-17 2009-02-12 Yoram Palti Treating parasites with electric fields
US20090048642A1 (en) * 2006-02-21 2009-02-19 Teodor Goroszeniuk Neurostimulation
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US7706890B2 (en) 2002-10-02 2010-04-27 Standen Ltd Treating a tumor or the like with an electric field that is focused at a target region
US20110137229A1 (en) * 2000-02-17 2011-06-09 Yoram Palti Treating bacteria with electric fields
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
USRE43618E1 (en) 2000-02-17 2012-08-28 Novocure Ltd Method and apparatus for destroying dividing cells
US20150012079A1 (en) * 2006-02-21 2015-01-08 Teodor Goroszeniuk Neurostimulation for treating pain, improving function and other nervous system related conditions
WO2015005908A1 (en) * 2013-07-09 2015-01-15 Brandes Bonnie Therapeutic signal generator
WO2016049021A1 (en) * 2014-09-22 2016-03-31 Boston Scientific Neuromodulation Corporation Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity
WO2017175116A1 (en) * 2016-04-04 2017-10-12 Moshe Giladi Reducing motility of cancer cells using tumor treating fields (ttfields)
US9814881B2 (en) 2014-09-22 2017-11-14 Boston Scientific Neuromodulation Corporation Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity
US9833622B2 (en) 2014-09-22 2017-12-05 Boston Scientific Neuromodulation Corporation Devices and methods using a pathological frequency in electrical stimulation for pain management
US9901737B2 (en) 2014-09-22 2018-02-27 Boston Scientific Neuromodulation Corporation Systems and methods for providing therapy to a patient using intermittent electrical stimulation
US9925378B2 (en) 2014-09-22 2018-03-27 Boston Scientific Neuromodulation Corporation Devices and methods to use power spectrum or signal association for pain management
WO2020039390A1 (en) * 2018-08-23 2020-02-27 Carsten Hagemann Using alternating electric fields to increase permeability of the blood brain barrier
US11020592B2 (en) 2017-11-17 2021-06-01 Boston Scientific Neuromodulation Corporation Systems and methods for generating intermittent stimulation using electrical stimulation systems
JP2021106879A (en) * 2018-08-23 2021-07-29 カルシュテン・ハーゲマン Use of ac electric field for improving permeability of blood-brain barrier
US11596576B2 (en) * 2017-01-23 2023-03-07 Xibi DONG Acupuncture robot and intelligent acupuncture system and method
US11911612B2 (en) 2018-07-18 2024-02-27 Novocure Gmbh Using power loss density and related measures to quantify the dose of tumor treating fields (TTFields)

Families Citing this family (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6546290B1 (en) * 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy
US20030045922A1 (en) * 2001-08-29 2003-03-06 Nancy Northrop Skin treatment method and apparatus
US7127296B2 (en) * 2001-11-02 2006-10-24 Advanced Bionics Corporation Method for increasing the therapeutic ratio/usage range in a neurostimulator
US8233991B2 (en) 2002-02-04 2012-07-31 Boston Scientific Neuromodulation Corporation Method for programming implantable device
US7881805B2 (en) * 2002-02-04 2011-02-01 Boston Scientific Neuromodulation Corporation Method for optimizing search for spinal cord stimulation parameter settings
US7146223B1 (en) 2002-02-04 2006-12-05 Advanced Bionics Corporation Method for optimizing search for spinal cord stimulation parameter settings
WO2003089046A1 (en) * 2002-04-16 2003-10-30 Cyto Pulse Sciences, Inc. Method of treating biological materials with translating electrical fields and electrode polarity reversal
US20050049654A1 (en) * 2003-08-28 2005-03-03 Peter Lathrop Ultralight pre-programmed microprocessor based electrotherapy technology
US20060052846A1 (en) * 2004-09-08 2006-03-09 Chieh-Lin Liu Physical electrotherapy device
US20060190057A1 (en) * 2005-02-24 2006-08-24 Reese Edward W Synthetic traveling wave transcutaneous electrical stimulation device
US8929979B2 (en) 2006-06-19 2015-01-06 Highland Instruments, Inc. Apparatus and method for stimulation of biological tissue
US8892200B2 (en) 2006-06-19 2014-11-18 Highland Instruments, Inc. Systems and methods for stimulating tissue using focused energy
US9913976B2 (en) 2006-06-19 2018-03-13 Highland Instruments, Inc. Systems and methods for stimulating and monitoring biological tissue
US8718758B2 (en) * 2006-06-19 2014-05-06 Highland Instruments, Inc. Interface apparatus for stimulation of biological tissue
KR100725257B1 (en) * 2006-06-30 2007-06-04 김성수 Low frequency stimulator using the cell
US7877152B2 (en) * 2006-07-31 2011-01-25 JusJas LLC Bipolar stimulation/recording device with widely spaced electrodes
JP4910653B2 (en) * 2006-11-20 2012-04-04 オムロンヘルスケア株式会社 Low frequency treatment device
JP4910652B2 (en) * 2006-11-20 2012-04-04 オムロンヘルスケア株式会社 Low frequency treatment device
WO2009070709A1 (en) * 2007-11-26 2009-06-04 Micro Transponder Inc. Implantable driver with charge balancing
US9089707B2 (en) 2008-07-02 2015-07-28 The Board Of Regents, The University Of Texas System Systems, methods and devices for paired plasticity
WO2009070705A2 (en) * 2007-11-26 2009-06-04 Microtransponder Inc. Transfer coil architecture
US8457757B2 (en) 2007-11-26 2013-06-04 Micro Transponder, Inc. Implantable transponder systems and methods
CN102470246B (en) * 2009-07-10 2015-08-05 都柏林大学,爱尔兰都柏林国立大学 Stimulate the method and apparatus of psoas muscle and abdominal muscle
US9008781B2 (en) 2009-10-22 2015-04-14 The Research Foundation Of The City University Of New York Method and system for treatment of mobility dysfunction
WO2011050255A2 (en) 2009-10-22 2011-04-28 Research Foundation Of The City University Of New York Dipole electrical stimulation employing direct current for recovery from spinal cord injury
EP2544764A4 (en) * 2010-03-11 2014-05-07 Ronald J Weinstock Emf probe configurations for electro-modulation of ionic channels of cells and methods of use thereof
EP2547397A4 (en) * 2010-03-18 2014-05-14 Ronald J Weinstock System for diagnosing and treatment of diabetic symptoms
US20140148726A1 (en) 2010-10-21 2014-05-29 Timothy Andrew WAGNER Methods for detecting a condition
US8594783B2 (en) 2011-08-24 2013-11-26 Highland Instruments, Inc. Systems and methods for stimulating cellular function in tissue
US10485972B2 (en) 2015-02-27 2019-11-26 Thync Global, Inc. Apparatuses and methods for neuromodulation
US9440070B2 (en) 2012-11-26 2016-09-13 Thyne Global, Inc. Wearable transdermal electrical stimulation devices and methods of using them
CN204147427U (en) 2012-11-26 2015-02-11 塞恩克公司 Wearable electrocutaneous stimulation equipment
US9474891B2 (en) 2014-05-25 2016-10-25 Thync Global, Inc. Transdermal neurostimulator adapted to reduce capacitive build-up
US11033731B2 (en) 2015-05-29 2021-06-15 Thync Global, Inc. Methods and apparatuses for transdermal electrical stimulation
US10814131B2 (en) 2012-11-26 2020-10-27 Thync Global, Inc. Apparatuses and methods for neuromodulation
US10537703B2 (en) 2012-11-26 2020-01-21 Thync Global, Inc. Systems and methods for transdermal electrical stimulation to improve sleep
CN108355242B (en) 2013-01-21 2022-04-15 卡拉健康公司 Apparatus and method for controlling tremor
US9962546B2 (en) 2013-02-21 2018-05-08 Meagan Medical, Inc. Cutaneous field stimulation with disposable and rechargeable components
US10293161B2 (en) 2013-06-29 2019-05-21 Thync Global, Inc. Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state
JP6410369B2 (en) 2013-06-29 2018-10-24 セレヴァスト メディカル インク.Cerevast Medical Inc. Transcutaneous electrical stimulation device for correcting or inducing cognitive state
US9314084B2 (en) 2013-09-09 2016-04-19 Lisa Maldonado Clandestine lotion dispensing apparatus
WO2015131093A1 (en) 2014-02-27 2015-09-03 Thync, Inc. Methods and apparatuses for user control of neurostimulation
US9393430B2 (en) 2014-05-17 2016-07-19 Thync Global, Inc. Methods and apparatuses for control of a wearable transdermal neurostimulator to apply ensemble waveforms
US9333334B2 (en) 2014-05-25 2016-05-10 Thync, Inc. Methods for attaching and wearing a neurostimulator
CN106413805A (en) 2014-06-02 2017-02-15 卡拉健康公司 Systems and methods for peripheral nerve stimulation to treat tremor
US9833617B2 (en) * 2014-07-25 2017-12-05 Loyalty Based Innovations, LLC Apparatus and method for treating multiple tumors in patients with metastatic disease by electric fields
USD759803S1 (en) 2014-10-28 2016-06-21 Highland Instruments, Inc. Adjustable headpiece with anatomical markers
US11534608B2 (en) 2015-01-04 2022-12-27 Ist, Llc Methods and apparatuses for transdermal stimulation of the outer ear
US10426945B2 (en) 2015-01-04 2019-10-01 Thync Global, Inc. Methods and apparatuses for transdermal stimulation of the outer ear
CN112914514A (en) 2015-06-10 2021-06-08 卡拉健康公司 System and method for peripheral nerve stimulation to treat tremor with a detachable treatment and monitoring unit
US10603482B2 (en) 2015-09-23 2020-03-31 Cala Health, Inc. Systems and methods for peripheral nerve stimulation in the finger or hand to treat hand tremors
WO2017106411A1 (en) 2015-12-15 2017-06-22 Cerevast Medical, Inc. Electrodes having surface exclusions
US9956405B2 (en) 2015-12-18 2018-05-01 Thyne Global, Inc. Transdermal electrical stimulation at the neck to induce neuromodulation
WO2017106878A1 (en) 2015-12-18 2017-06-22 Thync Global, Inc. Apparatuses and methods for transdermal electrical stimulation of nerves to modify or induce a cognitive state
CA3011993A1 (en) 2016-01-21 2017-08-03 Cala Health, Inc. Systems, methods and devices for peripheral neuromodulation for treating diseases related to overactive bladder
US10646708B2 (en) 2016-05-20 2020-05-12 Thync Global, Inc. Transdermal electrical stimulation at the neck
AU2017293799B2 (en) 2016-07-08 2022-10-20 Cala Health, Inc. Systems and methods for stimulating n nerves with exactly n electrodes and improved dry electrodes
CN110809486A (en) 2017-04-03 2020-02-18 卡拉健康公司 Peripheral neuromodulation systems, methods, and devices for treating diseases associated with overactive bladder
US20190134388A1 (en) * 2017-11-09 2019-05-09 Hollywog Tens device
US11857778B2 (en) 2018-01-17 2024-01-02 Cala Health, Inc. Systems and methods for treating inflammatory bowel disease through peripheral nerve stimulation
US11278724B2 (en) 2018-04-24 2022-03-22 Thync Global, Inc. Streamlined and pre-set neuromodulators
JP7294812B2 (en) * 2019-01-09 2023-06-20 ヤーマン株式会社 beauty device
US11691011B2 (en) * 2019-05-15 2023-07-04 Black Diamond Creations, Llc Pain-relieving apparatus
US11890468B1 (en) 2019-10-03 2024-02-06 Cala Health, Inc. Neurostimulation systems with event pattern detection and classification

Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1532463A (en) * 1922-08-29 1925-04-07 Winterfield Arthur Electromedical apparatus
US1539299A (en) * 1923-03-15 1925-05-26 Charles W Cheney Electrotherapeutic massage appliance
US3718132A (en) * 1970-03-26 1973-02-27 Neuro Syst Inc Electrotherapy machine
US3851651A (en) * 1972-12-22 1974-12-03 P Icenbice Facial stimulating apparatus having sequentially energized electrodes
US4180079A (en) * 1978-03-16 1979-12-25 Wing Thomas W Electroacupuncture instrument
US4342317A (en) * 1980-04-01 1982-08-03 The Professional Staff Association Of The Rancho Los Amigos Hospital, Inc. Method of electrical muscle stimulation for treatment of scoliosis and other spinal deformities
US5097833A (en) * 1989-09-19 1992-03-24 Campos James M Transcutaneous electrical nerve and/or muscle stimulator
US5336255A (en) * 1993-01-11 1994-08-09 Kanare Donald M Electrical stimulation heat/cool pack
US5350415A (en) * 1993-03-08 1994-09-27 Jozef Cywinski Device for trophic stimulation of muscles
US5354320A (en) * 1991-09-12 1994-10-11 Biotronik Mess- Und Therapiegerate Gmbh & Co., Ingenieurburo Berlin Neurostimulator for production of periodic stimulation pulses
US5527357A (en) * 1994-06-24 1996-06-18 Springer, Jr.; George E. Apparatus for toning facial tissue
US5562718A (en) * 1994-06-03 1996-10-08 Palermo; Francis X. Electronic neuromuscular stimulation device
US5851223A (en) * 1991-05-21 1998-12-22 Medi Consultants, Inc. Combination non-intrusive analgesic neuroaugmentive system and method triple-modulated gigatens with optional bipolar spike
US5947897A (en) * 1995-12-28 1999-09-07 Otake; Tsutomu Medical electrode assembly and medical equipment provided with the medical electrode assembly
US6546290B1 (en) * 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2092004B (en) 1981-01-29 1985-05-15 Bio Medical Res Ltd Muscle stimulating apparatus
CA1202683A (en) 1982-06-25 1986-04-01 Electronic Health Machines Inc. Electronic acupuncture apparatus and method
AU714617B2 (en) 1996-04-04 2000-01-06 Medtronic, Inc. Living tissue stimulation and recording techniques
CA2228817C (en) 1997-02-07 2005-05-24 Boris Shloznikov Device for acupuncture therapy

Patent Citations (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1532463A (en) * 1922-08-29 1925-04-07 Winterfield Arthur Electromedical apparatus
US1539299A (en) * 1923-03-15 1925-05-26 Charles W Cheney Electrotherapeutic massage appliance
US3718132A (en) * 1970-03-26 1973-02-27 Neuro Syst Inc Electrotherapy machine
US3851651A (en) * 1972-12-22 1974-12-03 P Icenbice Facial stimulating apparatus having sequentially energized electrodes
US4180079A (en) * 1978-03-16 1979-12-25 Wing Thomas W Electroacupuncture instrument
US4342317A (en) * 1980-04-01 1982-08-03 The Professional Staff Association Of The Rancho Los Amigos Hospital, Inc. Method of electrical muscle stimulation for treatment of scoliosis and other spinal deformities
US5097833A (en) * 1989-09-19 1992-03-24 Campos James M Transcutaneous electrical nerve and/or muscle stimulator
US5851223A (en) * 1991-05-21 1998-12-22 Medi Consultants, Inc. Combination non-intrusive analgesic neuroaugmentive system and method triple-modulated gigatens with optional bipolar spike
US5354320A (en) * 1991-09-12 1994-10-11 Biotronik Mess- Und Therapiegerate Gmbh & Co., Ingenieurburo Berlin Neurostimulator for production of periodic stimulation pulses
US5336255A (en) * 1993-01-11 1994-08-09 Kanare Donald M Electrical stimulation heat/cool pack
US5350415A (en) * 1993-03-08 1994-09-27 Jozef Cywinski Device for trophic stimulation of muscles
US5562718A (en) * 1994-06-03 1996-10-08 Palermo; Francis X. Electronic neuromuscular stimulation device
US5527357A (en) * 1994-06-24 1996-06-18 Springer, Jr.; George E. Apparatus for toning facial tissue
US5947897A (en) * 1995-12-28 1999-09-07 Otake; Tsutomu Medical electrode assembly and medical equipment provided with the medical electrode assembly
US6546290B1 (en) * 2000-04-12 2003-04-08 Roamitron Holding S.A. Method and apparatus for electromedical therapy

Cited By (80)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090043346A1 (en) * 2000-02-17 2009-02-12 Yoram Palti Treating parasites with electric fields
US20050209642A1 (en) * 2000-02-17 2005-09-22 Yoram Palti Treating a tumor or the like with electric fields at different orientations
US20050209640A1 (en) * 2000-02-17 2005-09-22 Yoram Palti Treating a tumor or the like with an electric field
US8447396B2 (en) 2000-02-17 2013-05-21 Novocure Ltd. Treating bacteria with electric fields
US8447395B2 (en) 2000-02-17 2013-05-21 Novocure Ltd Treating bacteria with electric fields
USRE43618E1 (en) 2000-02-17 2012-08-28 Novocure Ltd Method and apparatus for destroying dividing cells
US20060167499A1 (en) * 2000-02-17 2006-07-27 Standen Ltd Treating a tumor or the like with electric fields at different orientations
US8175698B2 (en) 2000-02-17 2012-05-08 Novocure Ltd. Treating bacteria with electric fields
US20110137229A1 (en) * 2000-02-17 2011-06-09 Yoram Palti Treating bacteria with electric fields
US7890183B2 (en) 2000-02-17 2011-02-15 Novocure Ltd. Treating parasites with electric fields
US7599746B2 (en) 2000-02-17 2009-10-06 Standen Ltd Apparatus and method for preventing the spread of cancerous metastases and for elimination of metastases
US7599745B2 (en) 2000-02-17 2009-10-06 Standen Ltd Treating a tumor or the like with an electric field
US7565205B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US7565206B2 (en) 2000-02-17 2009-07-21 Standen Ltd. Treating a tumor or the like with electric fields at different orientations
US20050209641A1 (en) * 2000-02-17 2005-09-22 Yoram Palti Treating a tumor or the like with an electric field
US7519420B2 (en) 2002-10-02 2009-04-14 Standen Ltd Apparatus for selectively destroying dividing cells
US20060241547A1 (en) * 2002-10-02 2006-10-26 Yoram Palti Probe for treating a tumor or the like
US7467011B2 (en) 2002-10-02 2008-12-16 Standen Ltd Hat for treating a tumor or the like
US20060233867A1 (en) * 2002-10-02 2006-10-19 Yoram Palti Article of clothing for treating a tumor or the like
US8027738B2 (en) 2002-10-02 2011-09-27 Standen Ltd. Probe for treating a tumor or the like
US7912540B2 (en) 2002-10-02 2011-03-22 Standen Ltd. Article of clothing for treating a tumor or the like
US20060237019A1 (en) * 2002-10-02 2006-10-26 Yoram Palti Hat for treating a tumor or the like
US7706890B2 (en) 2002-10-02 2010-04-27 Standen Ltd Treating a tumor or the like with an electric field that is focused at a target region
US20070033660A1 (en) * 2002-10-02 2007-02-08 Yoram Palti Method for selectively destroying dividing cells
US20070028310A1 (en) * 2002-10-02 2007-02-01 Yoram Palti Apparatus for selectively destroying dividing cells
US8706261B2 (en) 2004-04-23 2014-04-22 Novocure Ltd. Treating a tumor or the like with electric fields at different frequencies
US8244345B2 (en) 2004-04-23 2012-08-14 Novocure Ltd Treating a tumor or the like with electric fields at different frequencies
US20050240228A1 (en) * 2004-04-23 2005-10-27 Yoram Palti Treating a tumor or the like with electric fields at different frequencies
WO2005115535A3 (en) * 2004-04-23 2006-04-06 Staden Ltd Treating a tumor or the like with electric fields at different frequencies
US8170684B2 (en) 2004-12-07 2012-05-01 Novocure Limited Electrodes for applying an electric field in-vivo over an extended period of time
US20060149341A1 (en) * 2004-12-07 2006-07-06 Yoram Palti Electrodes for applying an electric field in-vivo over an extended period of time
US7715921B2 (en) 2004-12-07 2010-05-11 Standen Ltd. Electrodes for applying an electric field in-vivo over an extended period of time
US20100179621A1 (en) * 2004-12-07 2010-07-15 Yoram Palti Electrodes for applying an electric field in-vivo over an extended period of time
US8718756B2 (en) 2005-10-03 2014-05-06 Novocure Limited Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US7917227B2 (en) 2005-10-03 2011-03-29 Standen Ltd. Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
WO2007039799A3 (en) * 2005-10-03 2007-07-12 Standen Ltd Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US20070225766A1 (en) * 2005-10-03 2007-09-27 Yoram Palti Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
CN112402798A (en) * 2005-10-03 2021-02-26 诺沃库勒有限责任公司 Optimizing electric field characteristics to increase the effect of an electric field on proliferating cells
WO2007039799A2 (en) * 2005-10-03 2007-04-12 Novocure Ltd. Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
US20100324547A1 (en) * 2005-10-03 2010-12-23 Yoram Palti Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
EP3804809A1 (en) * 2005-10-03 2021-04-14 Novocure GmbH Optimizing characteristics of an electric field to increase the field's effect on proliferating cells
WO2007096600A1 (en) * 2006-02-21 2007-08-30 Teodor Goroszniuk Improvements in and relating to neurostimulation
US20090048642A1 (en) * 2006-02-21 2009-02-19 Teodor Goroszeniuk Neurostimulation
US20150012079A1 (en) * 2006-02-21 2015-01-08 Teodor Goroszeniuk Neurostimulation for treating pain, improving function and other nervous system related conditions
US9308363B2 (en) * 2006-02-21 2016-04-12 Teodor Goroszeniuk Neurostimulation for treating pain, improving function and other nervous system related conditions
US8019414B2 (en) 2006-04-05 2011-09-13 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
US8406870B2 (en) 2006-04-05 2013-03-26 Novocure Ltd. Treating cancer using electromagnetic fields in combination with other treatment regimens
US8465533B2 (en) 2007-03-06 2013-06-18 Novocure Limited Treating cancer using electromagnetic fields in combination with photodynamic therapy
US20080221630A1 (en) * 2007-03-06 2008-09-11 Yoram Palti Treating cancer using electromagnetic fields in combination with photodynamic therapy
US10722727B2 (en) 2013-07-09 2020-07-28 Bonnie Brandes Therapeutic signal generator
WO2015005908A1 (en) * 2013-07-09 2015-01-15 Brandes Bonnie Therapeutic signal generator
WO2016049021A1 (en) * 2014-09-22 2016-03-31 Boston Scientific Neuromodulation Corporation Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity
US11110276B2 (en) 2014-09-22 2021-09-07 Boston Scientific Neuromodulation Corporation Devices and methods to use power spectrum or signal association for pain management
US9925378B2 (en) 2014-09-22 2018-03-27 Boston Scientific Neuromodulation Corporation Devices and methods to use power spectrum or signal association for pain management
US9925377B2 (en) 2014-09-22 2018-03-27 Boston Scientific Neuromodulation Corporation Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity
US10004902B2 (en) 2014-09-22 2018-06-26 Lowe Graham Jones PLLC Devices and methods using a pathological frequency in electrical stimulation for pain management
US10130816B2 (en) 2014-09-22 2018-11-20 Boston Scientific Neruomodulation Corporation Devices and methods to use power spectrum or signal association for pain management
US10369364B2 (en) 2014-09-22 2019-08-06 Boston Scientific Neuromodulation Corporation Devices and methods to use power spectrum or signal association for pain management
US11691012B2 (en) 2014-09-22 2023-07-04 Boston Scientific Neuromodulation Corporation Devices and methods to use power spectrum or signal association for pain management
US9833622B2 (en) 2014-09-22 2017-12-05 Boston Scientific Neuromodulation Corporation Devices and methods using a pathological frequency in electrical stimulation for pain management
US9901737B2 (en) 2014-09-22 2018-02-27 Boston Scientific Neuromodulation Corporation Systems and methods for providing therapy to a patient using intermittent electrical stimulation
US9814881B2 (en) 2014-09-22 2017-11-14 Boston Scientific Neuromodulation Corporation Systems and methods for providing therapy using electrical stimulation to disrupt neuronal activity
US11191956B2 (en) 2016-04-04 2021-12-07 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
US10821283B2 (en) 2016-04-04 2020-11-03 Novocure Gmbh Reducing motility of cancer cells using tumor treating fields (TTFields)
WO2017175116A1 (en) * 2016-04-04 2017-10-12 Moshe Giladi Reducing motility of cancer cells using tumor treating fields (ttfields)
US11596576B2 (en) * 2017-01-23 2023-03-07 Xibi DONG Acupuncture robot and intelligent acupuncture system and method
US11020592B2 (en) 2017-11-17 2021-06-01 Boston Scientific Neuromodulation Corporation Systems and methods for generating intermittent stimulation using electrical stimulation systems
US11911612B2 (en) 2018-07-18 2024-02-27 Novocure Gmbh Using power loss density and related measures to quantify the dose of tumor treating fields (TTFields)
EP3892219A1 (en) * 2018-08-23 2021-10-13 Novocure GmbH Using alternating electric fields to increase permeability of the blood brain barrier
CN112469352A (en) * 2018-08-23 2021-03-09 卡斯滕·哈格曼 Use of alternating electric fields to increase permeability of the blood brain barrier
EP3878389A1 (en) * 2018-08-23 2021-09-15 Carsten Hagemann Using alternating electric fields to increase permeability of the blood brain barrier
US10967167B2 (en) 2018-08-23 2021-04-06 Carsten Hagemann Using alternating electric fields to increase permeability of the blood brain barrier
EP3895643A1 (en) * 2018-08-23 2021-10-20 Novocure GmbH Using alternating electric fields to increase permeability of the blood brain barrier
JP2021522957A (en) * 2018-08-23 2021-09-02 カルシュテン・ハーゲマン Use of alternating electric fields to improve the permeability of the blood-brain barrier
US11351349B2 (en) 2018-08-23 2022-06-07 Novocure Gmbh Using alternating electric fields to increase permeability of the blood brain barrier
US11400269B2 (en) 2018-08-23 2022-08-02 Novocure Gmbh Using alternating electric fields to increase permeability of the blood brain barrier
JP7233453B2 (en) 2018-08-23 2023-03-06 ノボキュア ゲーエムベーハー Use of alternating electric fields to improve permeability of the blood-brain barrier
JP2021106879A (en) * 2018-08-23 2021-07-29 カルシュテン・ハーゲマン Use of ac electric field for improving permeability of blood-brain barrier
WO2020039390A1 (en) * 2018-08-23 2020-02-27 Carsten Hagemann Using alternating electric fields to increase permeability of the blood brain barrier
EP3804648A1 (en) * 2018-08-23 2021-04-14 Carsten Hagemann Using alternating electric fields to increase permeability of the blood brain barrier

Also Published As

Publication number Publication date
EP1282457A1 (en) 2003-02-12
AU5206901A (en) 2001-10-30
EA200201085A1 (en) 2003-04-24
JP2003530920A (en) 2003-10-21
CA2405867A1 (en) 2001-10-25
ATE311926T1 (en) 2005-12-15
DE60115633D1 (en) 2006-01-12
WO2001078834A1 (en) 2001-10-25
EA005742B1 (en) 2005-06-30
IL152223A0 (en) 2003-05-29
AU2001252069B2 (en) 2005-04-14
WO2001078834A8 (en) 2002-02-07
KR20030003722A (en) 2003-01-10
EP1282457B1 (en) 2005-12-07
US6546290B1 (en) 2003-04-08

Similar Documents

Publication Publication Date Title
EP1282457B1 (en) Apparatus for electromedical therapy
AU2001252069A1 (en) Apparatus for electromedical therapy
US5674261A (en) S-shaped electrotherapy massage stick
CN103124583B (en) The system and method for sensation nerve
KR960012203B1 (en) Low-frequency electrotherapeutic device
US5540735A (en) Apparatus for electro-stimulation of flexing body portions
US6023642A (en) Compact transcutaneous electrical nerve stimulator
US20070060975A1 (en) Combination electrode-battery and programming assembly for a miniature wireless transcutaneous electrical neuro or muscular-stimulation unit
US20020193844A1 (en) Combination electrode-battery assembly for a miniature wireless transcutaneous electrical neuro or muscular-stimulation unit
JPH08511445A (en) Nerve stimulator and link support
US8041430B2 (en) TENS application devices
JP2011505981A (en) Apparatus and method for dermatome stimulation
JP2004535235A (en) Electroacupuncture device with D-shaped stimulation electrode
GB2228683A (en) Electro-therapy apparatus
KR20080099292A (en) Apparatus for non-invasive stimulation of an animal
US7200444B2 (en) Method and device for electro-acupuncture
KR20210027725A (en) Ultrasonic and low frequency therapy device
KR20180022816A (en) A plurality of cathodes
JP2021510328A (en) Electrode patch
DE DOMENICO et al. Motor stimulation with interferential currents
JPH07194711A (en) Gloves for electric treating instrument
US11420042B2 (en) Systems and methods for delivering neurostimulation using exogenous electrodes
KR102005026B1 (en) Patch and low-frequency therapy apparatus using the same
KR200291466Y1 (en) A cupping glass comprising low frequency device
RU44054U1 (en) ELECTRONEUROADAPTIVE STIMULANT (OPTIONS) AND ELECTRODE DEVICE

Legal Events

Date Code Title Description
AS Assignment

Owner name: ROAMITRON HOLDING S.A., LUXEMBOURG

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHLOZNIKOV, BORIS;REEL/FRAME:013946/0647

Effective date: 20010802

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION